Role of GABAB receptors in learning and memory and neurological disorders

Neuroscience and Biobehavioral Reviews

Volumn 63, Issue , 2016, Pages 1-28

  Heaney, Chelcie F ^a   Kinney, Jefferson W ^b  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^b UNIVERSITY OF NEVADA   (United States)

Author keywords

Cognition; GABAB receptor; Learning and memory; Neuropsychological disorders

Indexed keywords

4 AMINOBUTYRIC ACID B RECEPTOR; 4 AMINOBUTYRIC ACID RECEPTOR; 4 AMINOBUTYRIC ACID;

ACTIVE AVOIDANCE; ADDICTION; ALZHEIMER DISEASE; AUTISM; BARNES MAZE TEST; BEHAVIOR; BRAIN FUNCTION; CELL ACTIVITY; CONDITIONAL SPACE COLOR TASK; CONDITIONED FEAR; CONDITIONED TASTE AVERSION; DEFENSIVE BEHAVIOR; DISEASE ACTIVITY; DISEASE ASSOCIATION; EPILEPSY; FUNCTIONAL ASSESSMENT; HUMAN; IN VITRO STUDY; LEARNING; LONG TERM POTENTIATION; MEMORY; MENTAL TASK; MOLECULAR PATHOLOGY; MOOD DISORDER; MORRIS WATER MAZE TEST; NERVE CELL PLASTICITY; NERVOUS SYSTEM DEVELOPMENT; NEUROLOGIC DISEASE; NONHUMAN; NOVEL OBJECT RECOGNITION TEST; OSCILLATION; PASSIVE AVOIDANCE; PLACE PREFERENCE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN TARGETING; RADIAL ARM MAZE TEST; REVIEW; SCHIZOPHRENIA; SOCIAL INTERACTION; STIMULUS RESPONSE; TASK PERFORMANCE; TASTE AVERSION; WORKING MEMORY; ANIMAL; ANIMAL BEHAVIOR; BRAIN; CONDITIONED REFLEX; FEAR; MENTAL DISEASE; METABOLISM; NERVE CELL; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; BEHAVIOR, ANIMAL; BRAIN; CONDITIONING, CLASSICAL; FEAR; GAMMA-AMINOBUTYRIC ACID; HUMANS; LEARNING; LONG-TERM POTENTIATION; MEMORY; MENTAL DISORDERS; NEUROGENESIS; NEURONS; RECEPTORS, GABA-B;

EID: 84957100358     PISSN: 01497634     EISSN: 18737528     Source Type: Journal    
DOI: 10.1016/j.neubiorev.2016.01.007     Document Type: Review

References (448)

1. Addolorato G., Leggio L., Abenavoli L., Agabio R., Caputo F., Capristo E., Colombo G., Gessa G.L., Gasbarrini G. Baclofen in the treatment of alcohol withdrawal syndrome: a comparative study vs diazepam. Am. J. Med. 2006, 119. 276-e18. 10.1016/j.amjmed.2005.08.042.
2. (+) current desensitization. Biochem. Pharmacol. 2014, 10.1016/j.bcp.2014.07.013.
3. Agrawal A., Pergadia M.L., Saccone S.F., Hinrichs A.L., Lessov-Schlaggar C.N., Saccone N.L., Neuman R.J., Breslau N., Johnson E., Hatsukami D., Montgomery G.W., Heath A.C., Martin N.G., Goate A.M., Rice J.P., Bierut L.J., Madden P.A.F. Gamma-aminobutyric acid receptor genes and nicotine dependence: evidence for association from a case-control study. Addiction 2008, 103:1027-1038. 10.1111/j.1360-0443.2008.02236.x.
4. Akirav I., Maroun M. Ventromedial prefrontal cortex is obligatory for consolidation and reconsolidation of object recognition memory. Cereb. Cortex 2006, 16:1759-1765. 10.1093/cercor/bhj114.
5. Ambrogi Lorenzini C.G., Baldi E., Bucherelli C., Tassoni G. Post-training nucleus basalis magnocellularis functional tetrodotoxin blockade effects on passive-avoidance consolidation in the rat. Behav. Brain Res. 1994, 61:191-196.
6. Ambrogi Lorenzini C.G., Baldi E., Bucherelli C., Sacchetti B., Tassoni G. Role of dorsal hippocampus in acquisition, consolidation and retrieval of rat's passive avoidance response: a tetrodotoxin functional inactivation study. Brain Res. 1996, 730:32-39. 10.1016/0006-8993(96)00427-1.
7. Ambrogi Lorenzini C.G., Baldi E., Bucherelli C., Sacchetti B., Tassoni G. Role of ventral hippocampus in acquisition, consolidation and retrieval of rat's passive avoidance response memory trace. Brain Res. 1997, 768:242-248.
8. Andrews-Zwilling Y., Bien-Ly N., Xu Q., Li G., Bernardo A., Yoon S.Y., Zwilling D., Yan T.X., Chen L., Huang Y. Apolipoprotein E4 causes age- and Tau-dependent impairment of GABAergic interneurons, leading to learning and memory deficits in mice. J. Neurosci. 2010, 30:13707-13717. 10.1523/JNEUROSCI.4040-10.2010.
9. Antunes R., Moita M.A. Discriminative auditory fear learning requires both tuned and nontuned auditory pathways to the amygdala. J. Neurosci. 2010, 30:9782-9787. 10.1523/JNEUROSCI.1037-10.2010.
10. Arai S., Takuma K., Mizoguchi H., Ibi D., Nagai T., Takahashi K., Kamei H., Nabeshima T., Yamada K. Involvement of pallidotegmental neurons in methamphetamine- and MK-801-induced impairment of prepulse inhibition of the acoustic startle reflex in mice: reversal by GABAB receptor agonist baclofen. Neuropsychopharmacology 2008, 33:3164-3175. 10.1038/npp.2008.41.
11. Arolfo M.P., Zanudio M.A., Ramirez O.A. Baclofen infused in rat hippocampal formation impairs spatial learning. Hippocampus 1998, 8:109-113. http://dx.doi.org/10.1002/(SICI)1098-1063(1998)8:23.0.CO;2-G.
12. Aronica E., Redeker S., Boer K., Spliet W.G.M., van Rijen P.C., Gorter J.A., Troost D. Inhibitory networks in epilepsy-associated gangliogliomas and in the perilesional epileptic cortex. Epilepsy Res. 2007, 74:12. 10.1016/j.eplepsyres.2006.12.002.
13. + signaling in dopamine neurons of the ventral tegmental area. J. Neurosci. 2011, 31:12251-12257. 10.1523/JNEUROSCI.0494-11.2011.
14. Axmacher N., Mormann F., Fernández G., Elger C.E., Fell J. Memory formation by neuronal synchronization. Brain Res. Rev. 2006, 52:170-182. 10.1016/j.brainresrev.2006.01.007.
15. Bahar A., Dorfman N., Dudai Y. Amygdalar circuits required for either consolidation or extinction of taste aversion memory are not required for reconsolidation. Eur. J. Neurosci. 2004, 19:1115-1118. 10.1111/j.0953-816X.2004.03215.x.
16. Bai X., Edden R.A.E., Gao F., Wang G., Wu L., Zhao B., Wang M., Chan Q., Chen W., Barker P.B. Decreased γ-aminobutyric acid levels in the parietal region of patients with Alzheimer's disease. J. Magn. Reson. Imaging 2014, 10.1002/jmri.24665.
17. Balla A., Nattini M.E., Sershen H., Lajtha A., Dunlop D.S., Javitt D.C. GABAB/NMDA receptor interaction in the regulation of extracellular dopamine levels in rodent prefrontal cortex and striatum. Neuropharmacology 2009, 56:915-921. 10.1016/j.neuropharm.2009.01.021.
18. Bañuelos C., Beas B.S., McQuail J.A., Gilbert R.J., Frazier C.J., Setlow B., Bizon J.L. Prefrontal cortical GABAergic dysfunction contributes to age-related working memory impairment. J. Neurosci. 2014, 34:3457-3466. 10.1523/JNEUROSCI.5192-13.2014.
19. Barr M.S., Farzan F., Tran L.C., Chen R., Fitzgerald P.B., Daskalakis Z.J. Evidence for excessive frontal evoked gamma oscillatory activity in schizophrenia during working memory. Schizophr. Res. 2010, 121:146-152. 10.1016/j.schres.2010.05.023.
20. Bartoletti M., Ricci F., Gaiardi M. A GABA(B) agonist reverses the behavioral sensitization to morphine in rats. Psychopharmacology (Berl.) 2007, 192:79-85. 10.1007/s00213-006-0693-8.
21. Basar-Eroglu C., Brand A., Hildebrandt H., Kedzior K.K., Mathes B., Schmiedt C. Working memory related gamma oscillations in schizophrenia patients. Int. J. Psychophysiol. 2007, 64:39-45. 10.1016/j.ijpsycho.2006.07.007.
22. Begenisic T., Baroncelli L., Sansevero G., Milanese M., Bonifacino T., Bonanno G., Cioni G., Maffei L., Sale A. Fluoxetine in adulthood normalizes GABA release and rescues hippocampal synaptic plasticity and spatial memory in a mouse model of Down syndrome. Neurobiol. Dis. 2013, 63C:12-19. 10.1016/j.nbd.2013.11.010.
23. Benes F.M. Amygdalocortical circuitry in schizophrenia: from circuits to molecules. Neuropsychopharmacology 2010, 35:1239. 10.1038/npp.2010.22.
24. Berman D.E., Dudai Y. Memory extinction, learning anew, and learning the new: dissociations in the molecular machinery of learning in cortex. Science 2001, 291:2417-2419. 10.1126/science.1058165.
25. Bermudez-Rattoni F., McGaugh J.L. Insular cortex and amygdala lesions differentially affect acquisition on inhibitory avoidance and conditioned taste aversion. Brain Res. 1991, 549:165-170.
26. Best T.K., Cramer N.P., Chakrabarti L., Haydar T.F., Galdzicki Z. Dysfunctional hippocampal inhibition in the Ts65Dn mouse model of Down syndrome. Exp. Neurol. 2012, 233:749-757. 10.1016/j.expneurol.2011.11.033.
27. Best T.K., Siarey R.J., Galdzicki Z. Ts65Dn, a mouse model of Down syndrome, exhibits increased GABAB-induced potassium current. J. Neurophysiol. 2007, 97:892-900. 10.1152/jn.00626.2006.
28. Bettler B., Kaupmann K., Mosbacher J.J., Gassmann M. Molecular structure and physiological functions of GABA(B) receptors. Physiol. Rev. 2004, 84:835-867. 10.1152/physrev.00036.2003.
29. Beuten J., Ma J.Z., Payne T.J., Dupont R.T., Crews K.M., Somes G., Williams N.J., Elston R.C., Li M.D. Single- and multilocus allelic variants within the GABAB receptor subunit 2 (GABAB2) gene are significantly associated with nicotine dependence. Am. J. Hum. Genet. 2005, 76:6. 10.1086/429839.
30. Bhandage A.K., Jin Z., Bazov I., Kononenko O., Bakalkin G., Korpi E.R., Birnir B. GABA-A and NMDA receptor subunit mRNA expression is altered in the caudate but not the putamen of the postmortem brains of alcoholics. Front. Cell. Neurosci. 2014, 8:415. 10.3389/fncel.2014.00415.
31. Bianchi M.S., Lux-Lantos V.A., Bettler B., Libertun C. Expression of gamma-aminobutyric acid B receptor subunits in hypothalamus of male and female developing rats. Brain Res. Dev. Brain Res. 2005, 160:124-129. 10.1016/j.devbrainres.2005.06.017.
32. Billinton A., Ige A.O., Bolam J.P., White J.H., Marshall F.H., Emson P.C. Advances in the molecular understanding of GABA(B) receptors. Trends Neurosci. 2001, 24:277-282. 10.1016/S0166-2236(00)01815-4.
33. Bimonte H.A., Hyde L.A., Hoplight B.J., Denenberg V.H. In two species, females exhibit superior working memory and inferior reference memory on the water radial-arm maze. Physiol. Behav. 2000, 70:311-317. 10.1016/S0031-9384(00)00259-6.
34. Bittiger H., Froestl W., Mickel S.J., Olpe H.-R. GABAB receptor antagonists: from synthesis to therapeutic applications. Trends Pharmacol. Sci. 1993, 14:391-394. 10.1016/0165-6147(93) 90056-P.
35. Blichowski M., Shephard A., Armstrong J., Shen L., Cortez M.A., Eubanks J.H., Snead O.C. The GIRK2 subunit is involved in IS-like seizures induced by GABAB receptor agonists. Epilepsia 2015, 56:1081-1087. 10.1111/epi.13034.
36. Bolton M.M., Heaney C.F., Murtishaw A.S., Sabbagh J.J., Magcalas C.M., Kinney J.W. Postnatal alterations in GABA B receptor tone produce sensorimotor gating deficits and protein level differences in adulthood. Int. J. Dev. Neurosci. 2015, 41:17-27.
37. Booker S.A., Gross A., Althof D., Shigemoto R., Bettler B., Frotscher M., Hearing M., Wickman K., Watanabe M., Kulik A., Vida I. Differential GABAB-receptor-mediated effects in perisomatic- and dendrite-targeting parvalbumin interneurons. J. Neurosci. 2013, 33:7961-7974. 10.1523/JNEUROSCI.1186-12.2013.
38. Bortolato M., Frau R., Aru G.N., Orrù M., Gessa G.L. Baclofen reverses the reduction in prepulse inhibition of the acoustic startle response induced by dizocilpine, but not by apomorphine. Psychopharmacology (Berl.) 2004, 171:322-330.
39. Bortolato M., Frau R., Orrù M., Fà M., Dessì C.C., Puligheddu M., Barberini L.L., Pillolla G.G., Polizzi L.L., Santoni F., Mereu G., Marrosu F. GABAB receptor activation exacerbates spontaneous spike-and-wave discharges in DBA/2J mice. Seizure 2010, 19:6. 10.1016/j.seizure.2010.02.007.
40. Bortolato M., Frau R., Orrù M., Piras A.P., Fà M., Tuveri A., Puligheddu M., Gessa G.L., Castelli M.P., Mereu G. Activation of GABAB receptors reverses spontaneous gating deficits in juvenile DBA/2J mice. Psychopharmacology 2007, 194:361-369.
41. Boschen S.L., Wietzikoski E.C., Winn P., Cunha C.D. The role of nucleus accumbens and dorsolateral striatal D2 receptors in active avoidance conditioning. Neurobiol. Learn. Mem. 2011, 96:254-262. 10.1016/j.nlm.2011.05.002.
42. Bowery N.G. GABAB receptors and their significance in mammalian pharmacology. Trends Pharmacol. Sci. 1989, 10:401-407.
43. Bowery N.G., Hudson A.L., Price G.W. GABAA and GABAB receptor site distribution in the rat central nervous system. Neuroscience 1987, 20:365-383.
44. Brady R.O., McCarthy J.M., Prescot A.P., Jensen J.E., Cooper A.J., Cohen B.M., Renshaw P.F., Öngür D. Brain gamma-aminobutyric acid (GABA) abnormalities in bipolar disorder. Bipolar Disord. 2013, n/a-n/a. 10.1111/bdi.12074.
45. Branchi I., Alboni S., Maggi L. The role of microglia in mediating the effect of the environment in brain plasticity and behavior. Front. Cell. Neurosci. 2014, 8:390. 10.3389/fncel.2014.00390.
46. Braun J.J., Lasiter P.S., Kiefer S.W. The gustatory neocortex of the rat. Physiol. Psychol. 1982, 10.3758/BF03327004.
47. Brown J.T., Davies C.H., Randall A.D. Synaptic activation of GABA(B) receptors regulates neuronal network activity and entrainment. Eur. J. Neurosci. 2007, 25:2982-2990. 10.1111/j.1460-9568.2007.05544.x.
48. Brucato F.H., Levin E.D., Mott D.D., Lewis D.V., Wilson W.A., Swartzwelder H.S. Hippocampal long-term potentiation and spatial learning in the rat: effects of GABAB receptor blockade. Neuroscience 1996, 74:331-339. 10.1016/0306-4522(96) 00131-5.
49. Brucato F.H., Morrisett R.A., Wilson W.A., Swartzwelder H.S. The GABAB receptor antagonist, CGP-35348, inhibits paired-pulse disinhibition in the rat dentate gyrus in vivo. Brain Res. 1992, 588:150-153.
50. Brucato F.H., Mott D.D., Lewis D.V., Swartzwelder H.S. GABAB receptors modulate synaptically-evoked responses in the rat dentate gyrus, in vivo. Brain Res. 1995, 677:326-332.
51. Bruel-Jungerman E., Laroche S., Rampon C. New neurons in the dentate gyrus are involved in the expression of enhanced long-term memory following environmental enrichment. Eur. J. Neurosci. 2005, 21:513-521. 10.1111/j.1460-9568.2005.03875.x.
52. Bucherelli C., Tassoni G., BURES J. Time-dependent disruption of passive avoidance acquisition by post-training intra-amygdala injection of tetrodotoxin in rats. Neurosci. Lett. 1992, 140:231-234.
53. Burbaeva G.S., Boksha I.S., Tereshkina E.B., Savushkina O.K., Prokhorova T.A., Vorobyeva E.A. Glutamate and GABA-metabolizing enzymes in post-mortem cerebellum in alzheimer's disease: phosphate-activated glutaminase and glutamic acid decarboxylase. Cerebellum 2014, 13(October (5)):607-615. 10.1007/s12311-014-0573-4.
54. Burgard E.C., Sarvey J.M. Long-lasting potentiation and epileptiform activity produced by GABAB receptor activation in the dentate gyrus of rat hippocampal slice. J. Neurosci. 1991, 11:1198-1209.
55. Buzsaki G. Two-stage model of memory trace formation: a role for noisy brain states. Neuroscience 1989, 31:551-570.
56. Car H., Michaluk P. Baclofen influences acquisition and MMP-2, MMP-9 levels in the hippocampus of rats after hypoxia. Pharmacol. Rep. 2012, 64:536-545.
57. Car H., Wiśniewska R.J. Effects of baclofen and L-AP4 in passive avoidance test in rats after hypoxia-induced amnesia. Pharmacol. Rep. 2006, 58:91-100.
58. Car H., Wiśniewski K. The effect of baclofen and AP-7 on selected behavior in rats. Pharmacol. Biochem. Behav. 1998, 59:685-689.
59. Carletti R., Libri V., Bowery N.G. The gabab antagonist Cgp36742 enhances spatial learning performance and antagonises baclofen-induced amnesia in mice. Br. J. Pharmacol. 1993, 109:1P.
60. Castellano C., Brioni J.D., Nagahara A.H., McGaugh J.L. Post-training systemic and intra-amygdala administration of the GABA-B agonist baclofen impairs retention. Behav. Neural Biol. 1989, 52:170-179.
61. Castellano C., Cestari V., Cabib S., Puglisi-Allegra S. Strain-dependent effects of post-training GABA receptor agonists and antagonists on memory storage in mice. Psychopharmacology (Berl.) 1993, 111:134-138.
62. Cathomas F., Stegen M., Sigrist H., Schmid L., Seifritz E., Gassmann M., Bettler B., Pryce C.R. Altered emotionality and neuronal excitability in mice lacking KCTD12, an auxiliary subunit of GABAB receptors associated with mood disorders. Transl. Psychiatry 2015, 2015:e510.
63. Chan K.F.Y., Burnham W.M.W., Jia Z.Z., Cortez M.A.M., Snead O.C. GABAB receptor antagonism abolishes the learning impairments in rats with chronic atypical absence seizures. Eur. J. Pharmacol. 2006, 541:9. 10.1016/j.ejphar.2006.04.012.
64. Chapouthier G., Venault P. GABA-A receptor complex and memory processes. Curr. Top. Med. Chem. 2002, 2:841-851.
65. Chen C.-M.A., Stanford A.D., Mao X., Abi-Dargham A. GABA level, gamma oscillation, and working memory performance in schizophrenia. NeuroImage: Clin. 2014, 10.1016/j.nicl.2014.03.007.
66. Cherlyn S.Y.T., Woon P.S., Liu J.J., Ong W.Y., Tsai G.C., Sim K. Genetic association studies of glutamate GABA and related genes in schizophrenia and bipolar disorder: a decade of advance. Neurosci. Biobehav. Rev. 2010, 34:958-977. 10.1016/j.neubiorev.2010.01.002.
67. Cho R.Y., Konecky R.O., Carter C.S. Impairments in frontal cortical gamma synchrony and cognitive control in schizophrenia. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:19878-19883. 10.1073/pnas.0609440103.
68. Chowdhury N., Quinn J.J., Fanselow M.S. Dorsal hippocampus involvement in trace fear conditioning with long, but not short, trace intervals in mice. Behav. Neurosci. 2005, 119:1396-1402. 10.1037/0735-7044.119.5.1396.
69. Chrobak J.J., Napier T.C. Basal forebrain infusions impair delayed-non-match-to-sample radial arm maze performance. Pharmacol. Biochem. Behav. 2002, 72:209-212.
70. Chu D.C.M., Albin R., Young A.B., Penney J. Distribution and kinetics of GABAB binding sites in rat central nervous system: a quantitative autoradiographic study. Neuroscience 1990.
71. Chu D.C.M., Penney J.B., Young A.B. Quantitative autoradiography of hippocampal GABAB and GABAA receptor changes in Alzheimer's disease. Neurosci. Lett. 1987, 82:246-252. 10.1016/0304-3940(87) 90264-3.
72. Chu D.C.M., Penney J.B., Young A.B. Cortical GABAB and GABAA receptors in Alzheimer's disease a quantitative autoradiographic study. Neurology 1987, 37:1454.
73. Chu J., Gunraj C., Chen R. Possible differences between the time courses of presynaptic and postsynaptic GABAB mediated inhibition in the human motor cortex. Exp. Brain Res. 2008, 184:571-577. 10.1007/s00221-007-1125-7.
74. Clody D.E., Carlton P.L. Behavioral effects of lesions of the medial septum of rats. J. Comp. Physiol. Psychol. 1969, 67:344-351.
75. Colombo G., Agabio R., Carai M.A.M., Lobina C., Pani M., Reali R., Addolorato G., Gessa G.L. Ability of baclofen in reducing alcohol intake and withdrawal severity: I-preclinical evidence. Alcohol Clin. Exp. Res. 2000, 24:58-66. 10.1111/j.1530-0277.2000.tb04554.x.
76. Colombo G., Vacca G., Serra S., Brunetti G., Carai M.A.M., Gessa G.L. Baclofen suppresses motivation to consume alcohol in rats. Psychopharmacology (Berl.) 2003, 167:221-224. 10.1007/s00213-003-1397-y.
77. Couve A., Moss S.J., Pangalos M.N. GABAB receptors: a new paradigm in G protein signaling. Mol. Cell. Neurosci. 2000, 16:296-312. 10.1006/mcne.2000.0908.
78. Couve A., Thomas P., Calver A.R., Hirst W.D., Pangalos M.N., Walsh F.S., Smart T.G., Moss S.J. Cyclic AMP-dependent protein kinase phosphorylation facilitates GABA(B) receptor-effector coupling. Nat. Neurosci. 2002, 5:415-424. 10.1038/nn833.
79. Cryan J.F., Kelly P.H., Chaperon F., Gentsch C., Mombereau C., Lingenhoehl K., Froestl W., Bettler B., Kaupmann K., Spooren W.P. Behavioral characterization of the novel GABAB receptor-positive modulator GS39783 (N,N'-dicyclopentyl-2-methylsulfanyl-5-nitro-pyrimidine-4, 6-diamine): anxiolytic-like activity without side effects associated with baclofen or benzodiazepines. J. Pharmacol. Exp. Ther. 2004, 310:952-963. 10.1124/jpet.104.066753.
80. Cullen P.K., Dulka B.N., Ortiz S., Riccio D.C., Jasnow A.M. GABA-mediated presynaptic inhibition is required for precision of long-term memory. Learn. Mem. 2014, 21:180-184. 10.1101/lm.032961.113.
81. Davies S., Castaner J., Castaner R.M. Treatmentof Alzheimer's dementia treatment of attention deficit hyperactivity disorder GABAB receptor antagonist. Drugs Future 2005, 30:248-253.
82. de Lanerolle N.C., Kim J.H., Robbins R.J., Spencer D.D. Hippocampal interneuron loss and plasticity in human temporal lobe epilepsy. Brain Res. 1989, 495:387-395.
83. De Luca C., Massotti M. Phaclofen antagonizes the antinociceptive but not the sedative effects of (-)-baclofen. Prog. Neuropsychopharmacol. Biol. Psychiatry 1990, 14:597-607. 10.1016/0278-5846(90) 90011-5.
84. de Velasco E.M.F., Hearing M., Xia Z., Victoria N.C., Lujan R., Wickman K. Sex differences in GABA(B)R-GIRK signaling in layer 5/6 pyramidal neurons of the mouse prelimbic cortex. Neuropharmacology 2015, 95:353-360. 10.1016/j.neuropharm.2015.03.029.
85. Deacon R.M.J., Rawlins J.N.P. Learning impairments of hippocampal-lesioned mice in a paddling pool. Behav. Neurosci. 2002, 116:472-478.
86. Deisz R.A., Billard J.M., Zieglgänsberger W. Presynaptic and postsynaptic GABAB receptors of neocortical neurons of the rat in vitro: differences in pharmacology and ionic mechanisms. Synapse 1993, 154:209-212. 10.1002/(SICI)1098-2396(199701)25:13.0.CO;2-D.
87. DeLorey T.M., Sahbaie P.P., Hashemi E.E., Homanics G.E.G., Clark J.D. Gabrb3 gene deficient mice exhibit impaired social and exploratory behaviors, deficits in non-selective attention and hypoplasia of cerebellar vermal lobules: a potential model of autism spectrum disorder. Behav. Brain Res. 2008, 187:14. 10.1016/j.bbr.2007.09.009.
88. Deng C., Huang X.-F. Increased density of GABAA receptors in the superior temporal gyrus in schizophrenia. Exp. Brain Res. 2006, 168:587-590. 10.1007/s00221-005-0290-9.
89. + channels. Neuron 2009, 63:230-243. 10.1016/j.neuron.2009.06.022.
90. DeSousa N.J., Beninger R.J., Jhamandas K., Boegman R.J. Stimulation of GABA B receptors in the basal forebrain selectively impairs working memory of rats in the double Y-maze. Brain Res. 1994, 641:29-38.
91. Diniz L.P., Pereira Matias I.C., Garcia M., Alcantara Gomes F.C. Astrocytic control of neural circuit formation: highlights on TGF-beta signaling. Neurochem. Int. 2014, 10.1016/j.neuint.2014.07.008.
92. + and the glutamate/GABA hypotheses of epilepsy. Epilepsy Res. 2014, 108:995-1012. 10.1016/j.eplepsyres.2014.04.001.
93. Divac I., Wikmark R., Gade A. Spontaneous alternation in rats with lesions in the frontal lobes: an extension of the frontal lobe syndrome. Physiol. Psychol. 1975, 10.3758/BF03326820.
94. Dobrovitsky V., Pimentel P., Duarte A., Froestl W., Stellar J.R., Trzcińska M. CGP 44532, a GABAB receptor agonist, is hedonically neutral and reduces cocaine-induced enhancement of reward. Neuropharmacology 2002, 42:626-632.
95. Dokla C.P., Thal L.J. Nucleus basalis magnocellularis lesions facilitate two-way active avoidance. Physiol. Behav. 1989, 46:763-765.
96. Douglas R.J., Raphelson A.C. Spontaneous alternation and septal lesions. J. Comp. Physiol. Psychol. 1966, 62:320-322. 10.1037/h0023657.
97. Dubrovina N.I., Zinov'ev D.R. Contribution of GABA receptors to extinction of memory traces in normal conditions and in a depression-like state. Neurosci. Behav. Physiol. 2008, 38:775-779. 10.1007/s11055-008-9045-y.
98. Dugladze T., Maziashvili N., Börgers C., Gurgenidze S., Häussler U., Winkelmann A., Haas C.A., Meier J.C., Vida I., Kopell N.J., Gloveli T. GABAB autoreceptor-mediated cell type-specific reduction of inhibition in epileptic mice. Proc. Natl. Acad. Sci. U. S. A. 2013, 10.1073/pnas.1313505110.
99. During M.J., Spencer D.D. Extracellular hippocampal glutamate and spontaneous seizure in the conscious human brain. Lancet 1993, 341:1607-1610. 10.1016/0140-6736(93) 90754-5.
100. Dutar P., Nicoll R.A. Pre- and postsynaptic GABAB receptors in the hippocampus have different pharmacological properties. Neuron 1988, 1:585-591.
101. Eclancher F., Karli P. Effects of infant and adult amygdaloid lesions upon acquisition of two-way active avoidance by the adult rat: influence of rearing conditions. Physiol. Behav. 1980, 24:887-893. 10.1016/0031-9384(80) 90146-8.
102. Ekdahl C.T. Microglial activation-tuning and pruning adult neurogenesis. Front. Pharmacol. 2012, 3:41. 10.3389/fphar.2012.00041.
103. Enna S.J. The GABA receptors. GABA Recep. 2007, 1-21.
104. Enoch M.-A., Zhou Z., Kimura M., Mash D.C., Yuan Q., Goldman D. GABAergic gene expression in postmortem hippocampus from alcoholics and cocaine addicts; corresponding findings in alcohol-naïve P and NP rats. PLoS One 2012, 7 e29369. 10.1371/journal.pone.0029369.s006.
105. Enticott P.G., Kennedy H.A., Rinehart N.J., Tonge B.J., Bradshaw J.L., Fitzgerald P.B. GABAergic activity in autism spectrum disorders: an investigation of cortical inhibition via transcranial magnetic stimulation. Neuropharmacology 2013, 68:202-209. 10.1016/j.neuropharm.2012.06.017.
106. Erickson E.J., Watts K.D., Parent M.B. Septal co-infusions of glucose with a GABAB agonist impair memory. Neurobiol. Learn. Mem. 2006, 85:66-70. 10.1016/j.nlm.2005.08.008.
107. Escher T., Mittleman G. Effects of ethanol and GABA B drugs on working memory in C57BL/6J and DBA/2J mice. Psychopharmacology (Berl.) 2004, 176:167-175.
108. Falsafi S.K., Ghafari M., Miklósi A.G., Engidawork E., Gröger M., Höger H., Lubec G. Mouse hippocampal GABAB1 but not GABAB2 subunit-containing receptor complex levels are paralleling retrieval in the multiple-T-maze. Front. Behav. Neurosci. 2015, 9. 10.3389/fnbeh.2015.00276.
109. Farmer J., Zhao X., van Praag H., Wodtke K., Gage F.H., Christie B.R. Effects of voluntary exercise on synaptic plasticity and gene expression in the dentate gyrus of adult male Sprague-Dawley rats in vivo. Neuroscience 2004, 124:71-79. 10.1016/j.neuroscience.2003.09.029.
110. Farr S.A., Uezu K., Creonte T.A., Flood J.F., Morley J.E. Modulation of memory processing in the cingulate cortex of mice. Pharmacol. Biochem. Behav. 2000, 65:363-368. 10.1016/S0091-3057(99) 00226-9.
111. Fatemi S.H., Folsom T.D., Reutiman T.J., Thuras P.D. Expression of GABA B receptors is altered in brains of subjects with autism. Cerebellum 2009, 8:64-69.
112. Fatemi S.H., Folsom T.D., Reutiman T.J., Thuras P.D. Expression of GABAB receptors is altered in brains of subjects with autism. Cerebellum 2008, 8:64-69. 10.1007/s12311-008-0075-3.
113. Fatemi S.H., Folsom T.D., Thuras P.D.P. Deficits in GABA(B) receptor system in schizophrenia and mood disorders: a postmortem study. Schizophr. Res. 2011, 128:37-43. 10.1016/j.schres.2010.12.025.
114. Fatemi S.H., Halt A.R., Stary J.M., Kanodia R., Schulz S.C., Realmuto G.R. Glutamic acid decarboxylase 65 and 67 kDa proteins are reduced in autistic parietal and cerebellar cortices. Biol. Psychiatry 2002, 52:805-810. 10.1016/S0006-3223(02)01430-0.
115. Fatemi S.H., Reutiman T.J., Folsom T.D., Rooney R.J., Patel D.H., Thuras P.D. mRNA and protein levels for GABAAα4, α5, β1 and GABABR1 receptors are altered in brains from subjects with autism. J. Autism Dev. Disord. 2010, 40:743-750. 10.1007/s10803-009-0924-z.
116. Fatemi S.H., Stary J.M., Earle J.A., Araghi-Niknam M., Eagan E. GABAergic dysfunction in schizophrenia and mood disorders as reflected by decreased levels of glutamic acid decarboxylase 65 and 67 kDa and Reelin proteins in cerebellum. Neuropharmacology 2005, 72:109-122. 10.1016/j.schres.2004.02.017.
117. Fejgin K., Pålsson E., Wass C., Finnerty N., Lowry J., Klamer D. Prefrontal GABA(B) receptor activation attenuates phencyclidine-induced impairments of prepulse inhibition: involvement of nitric oxide. Neuropsychopharmacology 2009, 34:1673-1684. 10.1038/npp.2008.225.
118. Felice D., O'Leary O.F., Pizzo R.C., Cryan J.F. Blockade of the GABAB receptor increases neurogenesis in the ventral but not dorsal adult hippocampus: relevance to antidepressant action. Neuropharmacology 2012, 10.1016/j.neuropharm.2012.06.066.
119. Filip M., Frankowska M., Sadakierska-Chudy A., Suder A., Szumiec L., Mierzejewski P., Bienkowski P., Przegaliński E., Cryan J.F. GABAB receptors as a therapeutic strategy in substance use disorders: focus on positive allosteric modulators. Neuropharmacology 2014, 10.1016/j.neuropharm.2014.06.016.
120. Fiore M., Angelucci F., Alleva E., Branchi I., Probert L., Aloe L. Learning performances, brain NGF distribution and NPY levels in transgenic mice expressing TNF-alpha. Behav. Brain Res. 2000, 112:165-175. 10.1016/S0166-4328(00) 00180-7.
121. Floresco S.B., Seamans J.K., Phillips A.G. Selective roles for hippocampal, prefrontal cortical, and ventral striatal circuits in radial-arm maze tasks with or without a delay. J. Neurosci 1997, 17:1880-1890.
122. Florian C., Roullet P. Hippocampal CA3-region is crucial for acquisition and memory consolidation in Morris water maze task in mice. Behav. Brain Res. 2004, 154:365-374. 10.1016/j.bbr.2004.03.003.
123. Fogel S.M., Smith C.T., Beninger R.J. Increased GABAergic activity in the region of the pedunculopontine and deep mesencephalic reticular nuclei reduces REM sleep and impairs learning in rats. Behav. Neurosci. 2010, 124:79-86. 10.1037/a0018244.
124. Foster J.D., Kitchen I., Bettler B., Chen Y. GABAB receptor subtypes differentially modulate synaptic inhibition in the dentate gyrus to enhance granule cell output. Br. J. Pharmacol. 2013, 168:1808-1819. 10.1111/bph.12073.
125. Frankowska M., Filip M., Przegaliński E. Effects of GABAB receptor ligands in animal tests of depression and anxiety. Pharmacol. Rep. 2007, 59:645-655.
126. Frankowska M., Gołda A., Wydra K., Gruca P., Papp M., Filip M. Effects of imipramine or GABAB receptor ligands on the immobility, swimming and climbing in the forced swim test in rats following discontinuation of cocaine self-administration. Eur. J. Pharmacol. 2010, 627:8. 10.1016/j.ejphar.2009.10.049.
127. Frankowska M., Wydra K., Faron-Górecka A., Zaniewska M., Kuśmider M., Dziedzicka-Wasylewska M., Filip M. Neuroadaptive changes in the rat brain GABA B receptors after withdrawal from cocaine self-administration. Eur. J. Pharmacol. 2008, 599:58-64. 10.1016/j.ejphar.2008.09.018.
128. Frankowska M., Wydra K., Faron-Górecka A., Zaniewska M., Kuśmider M., Dziedzicka-Wasylewska M., Filip M. Alterations in gamma-aminobutyric acid(B) receptor binding in the rat brain after reinstatement of cocaine-seeking behavior. Pharmacol. Rep. 2008, 60:834-843.
129. Frau R., Bini V., Pillolla G., Malherbe P., Pardu A., Thomas A.W., Devoto P., Bortolato M. Positive allosteric modulation of GABAB receptors ameliorates sensorimotor gating in rodent models. CNS Neurosci. Ther. 2014, 20:679-684. 10.1111/cns.12261.
130. Froestl W., Cooke N.G., Mickel S.J. Chemistry of GABAB modulators. GABA Recep. 2007, 239-251.
131. Froestl W., Gallagher M., Jenkins H., Madrid A., Melcher T., Teichman S., Mondadori C., Pearlman R. SGS742: the first GABAB receptor antagonist in clinical trials. Biochem. Pharmacol. 2004, 68:1479-1487.
132. Froestl W., Mickel S.J., Sprecher von G., Diel P.J., Hall R.G., Maier L., Strub D., Melillo V., Baumann P.A. Phosphinic acid analogs of GABA. 2. Selective, orally active GABAB antagonists. J. Med. Chem. 1995, 38:3313-3331.
133. Furtinger S., Bettler B., Sperk G. Altered expression of GABAB receptors in the hippocampus after kainic-acid-induced seizures in rats. Brain Res. Mol. Brain Res. 2003, 113:107-115.
134. Gaïarsa J.-L., Porcher C. Emerging neurotrophic role of GABAB receptors in neuronal circuit development. Front. Cell. Neurosci. 2013, 7:206. 10.3389/fncel.2013.00206.
135. Gallo M., Roldan G., Bures J. Differential involvement of gustatory insular cortex and amygdala in the acquisition and retrieval of conditioned taste aversion in rats. Behav. Brain Res. 1992, 52:91-97.
136. Gandal M.J., Sisti J., Klook K., Ortinski P.I., Leitman V., Liang Y., Thieu T., Anderson R., Pierce R.C., Jonak G., Gur R.E., Carlson G., Siegel S.J. GABAB-mediated rescue of altered excitatory-inhibitory balance, gamma synchrony and behavioral deficits following constitutive NMDAR-hypofunction. Transl. Psychiatry 2012, 2. e142. 10.1038/tp.2012.69.
137. Gandhi C.C., Kelly1 R.M., Wiley R.G., Walsh T.J. Impaired acquisition of a Morris water maze task following selective destruction of cerebellar purkinje cells with OX7-saporin. Behav. Brain Res. 2000, 109:37-47.
138. Gassmann M., Shaban H., Vigot R., Sansig G., Haller C., Barbieri S., Humeau Y., Schuler V., Müller M., Kinzel B., Klebs K., Schmutz M., Froestl W., Heid J., Kelly P.H., Gentry C., Jaton A.-L., van der Putten H., Mombereau C., Lecourtier L., Mosbacher J., Cryan J.F., Fritschy J.-M., Lüthi A., Kaupmann K., Bettler B. Redistribution of GABAB(1) protein and atypical GABAB responses in GABAB(2)-deficient mice. J. Neurosci. 2004, 24:6086-6097. 10.1523/JNEUROSCI.5635-03.2004.
139. Ge S., Pradhan D.A., Ming G.-L., Song H. GABA sets the tempo for activity-dependent adult neurogenesis. Trends Neurosci. 2007, 30:1-8. 10.1016/j.tins.2006.11.001.
140. Gemma C., Bachstetter A.D. The role of microglia in adult hippocampal neurogenesis. Front. Cell. Neurosci. 2013, 7. 10.3389/fncel.2013.00229.
141. Genkova-Papazova M.G., Petkova B., Shishkova N., Lazarova-Bakarova M. The GABA-B antagonist CGP 36742 prevent PTZ-kindling-provoked amnesia in rats. Eur. Neuropsychopharmacol. 2000, 10:273-278.
142. Georgiev V.P., Yonkov D.I., Kambourova T.S. Interactions between angiotensin II and baclofen in shuttle-box and passive avoidance performance. Neuropeptides 1988, 12:155-158.
143. Getova D.P., Bowery N.G. Effects of high-affinity GABAB receptor antagonists on active and passive avoidance responding in rodents with gamma-hydroxybutyrolactone-induced absence syndrome. Psychopharmacology (Berl.) 2001, 157:89-95.
144. Getova D.P., Bowery N.G. The modulatory effects of high affinity GABA(B) receptor antagonists in an active avoidance learning paradigm in rats. Psychopharmacology (Berl.) 1998, 137:369-373.
145. Getova D.P., Bowery N.G., Spassov V. Effects of GABAB receptor antagonists on learning and memory retention in a rat model of absence epilepsy. Eur. J. Pharmacol. 1997, 320:9-13.
146. Getova D.P., Dimitrova D. Effects of GABA B receptor antagonists CGP63360, CGP76290A and CGP76291A on learning and memory processes in rodents. Central European Journal of Medicine 2007, 2:280-293.
147. Giachino C., Barz M., Tchorz J.S., Tome M., Gassmann M., Bischofberger J., Bettler B., Taylor V. GABA suppresses neurogenesis in the adult hippocampus through GABAB receptors. Development 2014, 141:83-90. 10.1242/dev.102608.
148. Gloveli T., Behr J., Dugladze T., Kokaia Z., Kokaia M., Heinemann U. Kindling alters entorhinal cortex-hippocampal interaction by increased efficacy of presynaptic GABA b autoreceptors in layer III of the entorhinal cortex. Neurobiol. Dis. 2003, 13:203-212. 10.1016/S0969-9961(03) 00039-1.
149. Golan H., Levav T., Mendelsohn A., Huleihel M. Involvement of tumor necrosis factor alpha in hippocampal development and function. Cereb. Cortex 2004, 14:97-105. 10.1093/cercor/bhg108.
150. Gong N., Li Y., Cai G.-Q., Niu R.-F., Fang Q., Wu K., Chen Z., Lin L.-N., Xu L., Fei J., Xu T.-L. GABA transporter-1 activity modulates hippocampal theta oscillation and theta burst stimulation-induced long-term potentiation. J. Neurosci. 2009, 29:15836-15845. 10.1523/JNEUROSCI.4643-09.2009.
151. Gonzalez-Burgos G., Hashimoto T., Lewis D.A. Alterations of cortical GABA neurons and network oscillations in schizophrenia. Curr. Psychiatry Rep. 2010, 12:335-344. 10.1007/s11920-010-0124-8.
152. Gould E., Beylin A., Tanapat P., Reeves A., Shors T.J. Learning enhances adult neurogenesis in the hippocampal formation. Nat. Neurosci. 1999, 2:260-265. 10.1038/6365.
153. Greenstein Y.J., Pavlides C., Winson J. Long-term potentiation in the dentate gyrus is preferentially induced at theta rhythm periodicity. Brain Res. 1988, 438:331-334.
154. Guery S., Floersheim P., Kaupmann K., Froestl W. Syntheses and optimization of new GS39783 analogues as positive allosteric modulators of GABAB receptors. Bioorg. Med. Chem. Lett. 2007, 17:6206-6211. 10.1016/j.bmc1.2007.09.023.
155. Guetg N., Aziz S.A., Holbro N., Turecek R., Rose T., Seddik R., Gassmann M., Moes S., Jenoe P., Oertner T.G., Casanova E., Bettler B. NMDA receptor-dependent GABAB receptor internalization via CaMKII phosphorylation of serine 867 in GABAB1. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:13924-13929. 10.1073/pnas.1000909107.
156. Guidotti A., Auta J., Davis J.M., Dong E., Grayson D.R., Veldic M., Zhang X., Costa E. GABAergic dysfunction in schizophrenia: new treatment strategies on the horizon. Psychopharmacology (Berl.) 2005, 180:191-205. 10.1007/s00213-005-2212-8.
157. Hamid E., Church E., Wells C.A., Zurawski Z., Hamm H.E., Alford S. Modulation of neurotransmission by GPCRs is dependent upon the microarchitecture of the primed vesicle complex. J. Neurosci. 2014, 34:260-274. 10.1523/JNEUROSCI.3633-12.2014.
158. Han X., Chen M., Wang F., Windrem M., Wang S., Shanz S., Xu Q., Oberheim N.A., Bekar L., Betstadt S., Silva A.J., Takano T., Goldman S.A., Nedergaard M. Forebrain engraftment by human glial progenitor cells enhances synaptic plasticity and learning in adult mice. Cell Stem Cell 2013, 12:342-353. 10.1016/j.stem.2012.12.015.
159. Harrison N.L., Lovinger D.M., Lambert N.A., Teyler T.J., Prager R., Ong J., Kerr D.I.B. The actions of 2-hydroxy-saclofen at presynaptic GABAB receptors in the rat hippocampus. Neurosci. Lett. 1990, 119:272-276.
160. Hasan A., Nitsche M.A., Herrmann M., Schneider-Axmann T., Marshall L., Gruber O., Falkai P., Wobrock T. Impaired long-term depression in schizophrenia: a cathodal tDCS pilot study. Brain Stimul. 2012, 5:475-483. 10.1016/j.brs.2011.08.004.
161. Hasan A., Wobrock T., Grefkes C., Labusga M., Levold K., Schneider-Axmann T., Falkai P., Müller H., Klosterkötter J., Bechdolf A. Deficient inhibitory cortical networks in antipsychotic-naive subjects at risk of developing first-episode psychosis and first-episode schizophrenia patients: a cross-sectional study. Biol. Psychiatry 2012, 72:744-751. 10.1016/j.biopsych.2012.03.005.
162. Hasuo H., Akasu T. Activation of inhibitory pathways suppresses the induction of long-term potentiation in neurons of the rat lateral septal nucleus. Neuroscience 2001, 105:343-352.
163. He P., Liu Q., Wu J., Shen Y. Genetic deletion of TNF receptor suppresses excitatory synaptic transmission via reducing AMPA receptor synaptic localization in cortical neurons. FASEB J. 2012, 26:334-345. 10.1096/fj.11-192716.
164. Heaney C.F., Bolton M.M., Murtishaw A.S., Sabbagh J.J., Magcalas C.M., Kinney J.W. Baclofen administration alters fear extinction and GABAergic protein levels. Neurobiol. Learn. Mem. 2012, 98:261-271. 10.1016/j.nlm.2012.09.005.
165. Heckers S., Stone D., Walsh J., Shick J., Koul P., Benes F.M. Differential hippocampal expression of glutamic acid decarboxylase 65 and 67 messenger RNA in bipolar disorder and schizophrenia. Arch. Gen. Psychiatry 2002, 59:521.
166. Heinrichs S.C., Leite-Morris K.A., Carey R.J., Kaplan G.B. Baclofen enhances extinction of opiate conditioned place preference. Behav. Brain Res. 2010, 207:353-359. 10.1016/j.bbr.2009.10.013.
167. Helm K.A., Haberman R.P., Dean S.L., Hoyt E.C., Melcher T., Lund P.K., Gallagher M. GABAB receptor antagonist SGS742 improves spatial memory and reduces protein binding to the cAMP response element (CRE) in the hippocampus. Neuropharmacology 2005, 48:956-964. 10.1016/j.neuropharm.2005.01.019.
168. Henderson C., Wijetunge L., Kinoshita M.N., Shumway M., Hammond R.S., Postma F.R., Brynczka C., Rush R., Thomas A., Paylor R., Warren S.T., Vanderklish P.W., Kind P.C., Carpenter R.L., Bear M.F., Healy A.M. Reversal of disease-related pathologies in the fragile X mouse model by selective activation of GABAB receptors with arbaclofen. Sci. Transl. Med. 2012, 4. 152ra128-152ra128. 10.1126/scitranslmed.3004218.
169. Hensler J.G., Advani T., Burke T.F., Cheng K., Rice K.C., Koek W. GABAB receptor-positive modulators: brain region-dependent effects. J. Pharmacol. Exp. Ther. 2011, 340:19-26. 10.1124/jpet.111.186577.
170. Hernández-González S., Ballestín R., López-Hidalgo R., Gilabert-Juan J., Blasco-Ibáñez J.M., Crespo C., Nácher J., Varea E. Altered distribution of hippocampal interneurons in the murine Down syndrome model Ts65Dn. Neurochem. Res. 2014, 10.1007/s11064-014-1479-8.
171. Hollnagel J.O., Maslarova A., Haq R.U., Heinemann U. GABAB receptor dependent modulation of sharp wave-ripple complexes in the rat hippocampus in vitro. Neurosci. Lett. 2014, 574:15-20. 10.1016/j.neulet.2014.04.045.
172. Hölscher C., Anwyl R., Rowan M.J. Stimulation on the positive phase of hippocampal theta rhythm induces long-term potentiation that can Be depotentiated by stimulation on the negative phase in area CA1 in vivo. J. Neurosci. 1997, 17:6470-6477.
173. Huang C.S., Shi S.-H., Ule J., Ruggiu M., Barker L.A., Darnell R.B., Jan Y.N., Jan L.Y. Common molecular pathways mediate long-term potentiation of synaptic excitation and slow synaptic inhibition. Cell 2005, 123:105-118. 10.1016/j.cell.2005.07.033.
174. Huff N.C., Rudy J.W. The amygdala modulates hippocampus-dependent context memory formation and stores cue-shock associations. Behav. Neurosci. 2004, 118:53-62. 10.1037/0735-7044.118.1.53.
175. Hunt R.F., Girskis K.M., Rubenstein J.L., Alvarez-Buylla A., Baraban S.C. GABA progenitors grafted into the adult epileptic brain control seizures and abnormal behavior. Nat. Neurosci. 2013, 16:692-697. 10.1038/nn.3392.
176. Hüttmann K., Yilmazer-Hanke D., Seifert G., Schramm J., Pape H.-C., Steinhäuser C. Molecular and functional properties of neurons in the human lateral amygdala. Mol. Cell. Neurosci. 2006, 31:8. 10.1016/j.mcn.2005.09.011.
177. Hyman J.M., Wyble B.P., Goyal V., Rossi C.A., Hasselmo M.E. Stimulation in hippocampal region CA1 in behaving rats yields long-term potentiation when delivered to the peak of theta and long-term depression when delivered to the trough. J. Neurosci. 2003, 23:11725-11731.
178. Inaba Y., D'Antuono M., Bertazzoni G., Biagini G., Avoli M. Diminished presynaptic GABA(B) receptor function in the neocortex of a genetic model of absence epilepsy. Neurosignals 2009, 17:121-131. 10.1159/000197864.
179. Inaguma Y., Shinohara H., Inagaki T., Kato K. Immunoreactive parvalbumin concentrations in parahippocampal gyrus decrease in patients with Alzheimer's disease. J. Neurol. Sci. 1992, 110:57-61.
180. Ishikawa M., Mizukami K., Iwakiri M., Asada T. Immunohistochemical and immunoblot analysis of gamma-aminobutyric acid B receptor in the prefrontal cortex of subjects with schizophrenia and bipolar disorder. Neurosci. Lett. 2005, 383:272-277. 10.1016/j.neulet.2005.04.025.
181. Iwakiri M., Mizukami K., Ikonomovic M.D., Ishikawa M., Hidaka S., Abrahamson E.E., DeKosky S.T., Asada T. Changes in hippocampal GABABR1 subunit expression in Alzheimer's patients: association with Braak staging. Acta Neuropathol. 2005, 109:467-474. 10.1007/s00401-005-0985-9.
182. Jacobson L.H., Kelly P.H., Bettler B., Kaupmann K., Cryan J.F. Specific roles of GABA(B(1)) receptor isoforms in cognition. Behav. Brain Res. 2007, 181:158-162. 10.1016/j.bbr.2007.03.033.
183. Jacobson L.H., Kelly P.H., Bettler B., Kaupmann K., Cryan J.F. GABA(B(1)) receptor isoforms differentially mediate the acquisition and extinction of aversive taste memories. J. Neurosci. 2006, 26:8800-8803. 10.1523/JNEUROSCI.2076-06.2006.
184. Jacobson L.H., Sweeney F.F., Kaupmann K., O'Leary O.F., Gassmann M., Bettler B., Cryan J.F. Differential roles of GABAB1 subunit isoforms on locomotor responses to acute and repeated administration of cocaine. Behav. Brain Res. 2016, 298:12-16. 10.1016/j.bbr.2015.10.039.
185. Janjua N.A., Mori A., Hiramatsu M. Gamma-aminobutyric acid uptake is decreased in the hippocampus in a genetic model of human temporal lobe epilepsy. Epilepsy Res. 1991, 8:71-74.
186. Jarrard L.E. Selective hippocampal lesions: differential effects on performance by rats of a spatial task with preoperative versus postoperative training. J. Comp. Physiol. Psychol. 1978, 92:1119-1127.
187. Jarrard L.E. Anatomical and behavioral analysis of hippocampal cell fields in rats. J. Comp. Physiol. Psychol. 1976, 90:1035-1050. 10.1037/h0078659.
188. Javitt D.C., Hashim A., Sershen H. Modulation of striatal dopamine release by glycine transport inhibitors. Neuropsychopharmacology 2005, 30:649-656. 10.1038/sj.npp.1300589.
189. Jessberger S., Clark R.E., Broadbent N.J., Clemenson G.D., Consiglio A., Lie D.C., Squire L.R., Gage F.H. Dentate gyrus-specific knockdown of adult neurogenesis impairs spatial and object recognition memory in adult rats. Learn. Mem. 2009, 16:147-154. 10.1101/lm.1172609.
190. Jiang X., Su L., Zhang Q., He C., Zhang Z., Yi P., Liu J. GABAB receptor complex as a potential target for tumor therapy. J. Histochem. Cytochem. 2012, 60:269-279.
191. Jo S., Yarishkin O., Hwang Y.J., Chun Y.E., Park M., Woo D.H., Bae J.Y., Kim T., Lee J., Chun H., Park H.J., Lee D.Y., Hong J., Kim H.Y., Oh S.-J., Park S.J., Lee H., Yoon B.-E., Kim Y., Jeong Y., Shim I., Bae Y.C., Cho J., Kowall N.W., Ryu H., Hwang E., Kim D., Lee C.J. GABA from reactive astrocytes impairs memory in mouse models of Alzheimer's disease. Nat. Med. 2014, 20:886-896. 10.1038/nm.3639.
192. Johnson C.T., Olton D.S., Gage F.H., Jenko P.G. Damage to hippocampus and hippocampal connections: effects on DRL and spontaneous alternation. J. Comp. Physiol. Psychol. 1977, 91:508-522.
193. Jutras M.J., Buffalo E.A. Synchronous neural activity and memory formation. Curr. Opin. Neurobiol. 2010, 20:150-155. 10.1016/j.conb.2010.02.006.
194. Kabashima N., Shibuya I., Ibrahim N., Ueta Y., Yamashita H. Inhibition of spontaneous EPSCs and IPSCs by presynaptic GABAB receptors on rat supraoptic magnocellular neurons. J. Physiol. 1997, 504:113-126. 10.1111/j.1469-7793.1997.113bf.x.
195. Kamiński R.M., Van Rijn C.M., Turski W.A., Czuczwar S.J., Van Luijtelaar G. AMPA and GABAB receptor antagonists and their interaction in rats with a genetic form of absence epilepsy. Eur. J. Pharmacol. 2001, 430:251-259. 10.1016/S0014-2999(01) 01393-0.
196. Kang J.-Q., Barnes G. A common susceptibility factor of both autism and epilepsy: functional deficiency of GABA(A) teceptors. J. Autism Dev. Disord. 2012, 10.1007/s10803-012-1543-7.
197. Kantrowitz J., Citrome L., Javitt D.C. GABAB receptors, schizophrenia and sleep dysfunction. CNS Drugs 2009, 23:681-691.
198. Kasten C.R., Boehm S.L. Identifying the role of pre-and postsynaptic GABAB receptors in behavior. Neurosci. Biobehav. Rev. 2015, 57:70-87. 10.1016/j.neubiorev.2015.08.007.
199. Keilhoff G., Bernstein H.-G., Becker A., Grecksch G., Wolf G. Increased neurogenesis in a rat ketamine model of schizophrenia. Biol. Psychiatry 2004, 56:317-322. 10.1016/j.biopsych.2004.06.010.
200. Kempermann G., Kuhn H.G., Gage F.H. More hippocampal neurons in adult mice living in an enriched environment. Nature 1997, 386:493-495. 10.1038/386493a0.
201. Kerr D.I.B., Ong J., Prager R.H., Gynther B.D., Curtis D.R. Phaclofen: a peripheral and central baclofen antagonist. Brain Res. 1987, 405:150-154.
202. (2+). Neuroscience 2015, 10.1016/j.neuroscience.2015.07.083.
203. Khedr E.M., Ahmed M.A., Darwish E.S., Ali A.M. The relationship between motor cortex excitability and severity of Alzheimer's disease: a transcranial magnetic stimulation study. Neurophysiol. Clin. 2011, 41:107-113.
204. Kim J.J., Fanselow M.S. Modality-specific retrograde amnesia of fear. Science 1992, 256(May (5057)):675-677.
205. Kim M., McGaugh J.L. Effects of intra-amygdala injections of NMDA receptor antagonists on acquisition and retention of inhibitory avoidance. Brain Res. 1992, 585:35-48. 10.1016/0006-8993(92) 91188-K.
206. Kleschevnikov A.M., Belichenko P.V., Faizi M., Jacobs L.F., Htun K., Shamloo M., Mobley W.C. Deficits in cognition and synaptic plasticity in a mouse model of Down syndrome ameliorated by GABAB receptor antagonists. J. Neurosci. 2012, 32:9217-9227. 10.1523/JNEUROSCI.1673-12.2012.
207. Kleschevnikov A.M., Belichenko P.V., Gall J., George L., Nosheny R., Maloney M.T., Salehi A., Mobley W.C. Increased efficiency of the GABAA and GABAB receptor-mediated neurotransmission in the Ts65Dn mouse model of Down syndrome. Neurobiol. Dis. 2012, 45:683-691. 10.1016/j.nbd.2011.10.009.
208. Kogan J.H., Frankland P.W., Silva A.J. Long-term memory underlying hippocampus-dependent social recognition in mice. Hippocampus 2000, 10:47-56. 10.1002/(SICI) 1098-1063(2000) 10:1<47:AID-HIPO5>3.0.CO;2-6.
209. Kohl M.M., Paulsen O. The roles of GABAB receptors in cortical network activity. Adv. Pharmacol. 2010, 58:205-229. 10.1016/S1054-3589(10) 58009-8.
210. Kreek M.J., Nielsen D.A., LaForge K.S. Genes associated with addiction: alcoholism, opiate, and cocaine addiction. Neuromolecular Med. 2004, 5:85-108. 10.1385/NMM:5:1:085.
211. Kreisel T., Frank M.G., Licht T., Reshef R., Ben-Menachem-Zidon O., Baratta M.V., Maier S.F., Yirmiya R. Dynamic microglial alterations underlie stress-induced depressive-like behavior and suppressed neurogenesis. Mol. Psychiatry 2013, 19:699-709. 10.1038/mp.2013.155.
212. Kuhn S.A., van Landeghem F.K.H., Zacharias R., Färber K., Rappert A., Pavlovic S., Hoffmann A., Nolte C., Kettenmann H. Microglia express GABA(B) receptors to modulate interleukin release. Mol. Cell. Neurosci. 2004, 25:312-322. 10.1016/j.mcn.2003.10.023.
213. Kuramoto M.E., Nobuyuki, Wilkins, Fairfax B.P., Revilla-Sanchez R., Terunuma M., Tamaki K., Iemata M., Warren N., Couve A., Calver A.R., Horvath Z., Freeman K., Carling D., Huang L., Gonzales C., Cooper E., Smart T.G., Pangalos M.N., Moss S.J. Phospho-dependent functional modulation of GABA B receptors by the metabolic sensor AMP-dependent protein kinase. Neuron 2007, 53:233-247.
214. Kuziemka-Leska M., Car H., Wiśniewski K. Baclofen and AII 3-7 on learning and memory processes in rats chronically treated with ethanol. Pharmacol. Biochem. Behav. 1999, 62:39-43.
215. Ladera C., del Carmen Godino M., Cabañero M.J., Torres M., Watanabe M., Lujan R., Sánchez-Prieto J. Pre-synaptic GABA receptors inhibit glutamate release through GIRK channels in rat cerebral cortex. J. Neurochem. 2008, 107:1506-1517. 10.1111/j.1471-4159.2008.05712.x.
216. Lang M., Moradi-Chameh H., Zahid T., Gane J., Wu C., Valiante T., Zhang L. Regulating hippocampal hyperexcitability through GABAB Receptors. Physiol. Rep. 2014, 2:e00278. 10.14814/phy2.278.
217. Larson J., Wong D., Lynch G. Patterned stimulation at the theta frequency is optimal for the induction of hippocampal long-term potentiation. Brain Res. 1986, 368:347-350. 10.1016/0006-8993(86)90579-2.
218. Laukkanen V., Storvik M., Häkkinen M., Akamine Y., Tupala E., Virkkunen M., Tiihonen J. Decreased GABAA benzodiazepine binding site densities in postmortem brains of Cloninger type 1 and 2 alcoholics. Alcohol 2013, 47:103-108. 10.1016/j.alcohol.2012.12.008.
219. LeDoux J.E. Emotion circuits in the brain. Annu. Rev. Neurosci. 2000, 23:155-184. 10.1146/annurev.neuro.23.1.155.
220. Lee I., Hunsaker M.R., Kesner R.P. The role of hippocampal subregions in detecting spatial novelty. Behav. Neurosci. 2005, 119:145-153. 10.1037/0735-7044.119.1.145.
221. Lee M.T.M., Chen C.H., Lee C.S., Chen C.C., Chong M.Y., Ouyang W.C., Chiu N.Y., Chuo L.J., Chen C.Y., Tan H.K.L., Lane H.Y., Chang T.J., Lin C.H., Jou S.H., Hou Y.M., Feng J., Lai T.J., Tung C.L., Chen T.J., Chang C.J., Lung F.W., Chen C.K., Shiah I.S., Liu C.Y., Teng P.R., Chen K.H., Shen L.J., Cheng C.S., Chang T.P., Li C.F., Chou C.H., Chen C.Y., Wang K.H.T., Fann C.S.J., Wu J.Y., Chen Y.T., Cheng A.T.A. Genome-wide association study of bipolar I disorder in the Han Chinese population. Mol. Psychiatry 2011, 16:548-556. 10.1038/mp.2010.43.
222. Leung L.S., Peloquin P., Canning K.J. Paired-pulse depression of excitatory postsynaptic current sinks in hippocampal CA1 in vivo. Hippocampus 2008, 18:1008-1020. 10.1002/hipo.20458.
223. Leung L.S., Shen B. GABAB receptor blockade enhances theta and gamma rhythms in the hippocampus of behaving rats. Hippocampus 2007, 17:281-291. 10.1002/hipo.20267.
224. Leung L.S., Wu C. Kindling suppresses primed-burst-induced long-term potentiation in hippocampal CA1. Neuroreport 2003, 14:211-214.
225. Levin E.D., Weber E., Icenogle L. Baclofen interactions with nicotine in rats: effects on memory. Pharmacol. Biochem. Behav. 2004, 79:343-348. 10.1016/j.pbb.2004.08.013.
226. Levinson A.J., Fitzgerald P.B., Favalli G., Blumberger D.M., Daigle M., Daskalakis Z.J. Evidence of cortical inhibitory deficits in major depressive disorder. Biol. Psychiatry 2010, 67:458-464. 10.1016/j.biopsych.2009.09.025.
227. Lewis D.A., Cho R.Y., Carter C.S., Eklund K., Forster S., Kelly M.A., Montrose D. Subunit-selective modulation of GABA type A receptor neurotransmission and cognition in schizophrenia. Am. J. Psychiatry 2008, 165:1585-1593. 10.1176/appi.ajp.2008.08030395.
228. Lewohl J.M., Wilson W.R., Mayfield R.D., Brozowski S.J., Morrisett R.A., Harris R.A. G-protein-coupled inwardly rectifying potassium channels are targets of alcohol action. Nat. Neurosci. 1999, 2:1084-1090. 10.1038/16012.
229. Lhuillier L., Mombereau C., Cryan J.F., Kaupmann K. GABAB receptor-positive modulation decreases selective molecular and behavioral effects of cocaine. Neuropsychopharmacology 2006, 32:388-398. 10.1038/sj.npp.1301102.
230. Li C.-J., Lu Y., Zhou M., Zong X.-G., Li C., Xu X.-L., Guo L.-J., Lu Q. Activation of GABAB receptors ameliorates cognitive impairment via restoring the balance of HCN1/HCN2 surface expression in the hippocampal CA1 area in rats with chronic cerebral hypoperfusion. Mol. Neurobiol. 2014, 50:704-720. 10.1007/s12035-014-8736-3.
231. Li G., Bien-Ly N., Andrews-Zwilling Y., Xu Q., Bernardo A., Ring K., Halabisky B., Deng C., Mahley R.W., Huang Y. GABAergic interneuron dysfunction impairs hippocampal neurogenesis in adult apolipoprotein E4 knockin mice. Cell Stem Cell 2009, 5:634-645. 10.1016/j.stem.2009.10.015.
232. Li S., Varga V., Sik A., Kocsis B. GABAergic control of the ascending input from the median raphe nucleus to the limbic system. J. Neurophysiol. 2005, 94:2561-2574. 10.1152/jn.00379.2005.
233. Li X., Kaczanowska K., Finn M.G., Markou A., Risbrough V.B. The GABAB receptor positive modulator BHF177 attenuated anxiety, but not conditioned fear, in rats. Neuropharmacology 2015, 97:357-364. 10.1016/j.neuropharm.2015.05.001.
234. Li X., Risbrough V.B., Cates-Gatto C., Kaczanowska K., Finn M.G., Roberts A.J., Markou A. Comparison of the effects of the GABAB receptor positive modulator BHF177 and the GABAB receptor agonist baclofen on anxiety-like behavior, learning, and memory in mice. Neuropharmacology 2013, 10.1016/j.neuropharm.2013.01.018.
235. Lin F.H., Cao Z., Hosford D.A. Increased number of GABAB receptors in the lethargic (lh/lh) mouse model of absence epilepsy. Brain Res. 1993, 608:101-106.
236. Liu J., Wang L.-N. Baclofen for alcohol withdrawal. Cochrane Database Syst. Rev. 2015, 4:CD008502. 10.1002/14651858.CD008502.pub4.
237. Liu Q.-Y., Wang C.-Y., Cai Z.-L., Xu S.-T., Liu W.-X., Xiao P., Li C.-H. Effects of intrahippocampal GABAB receptor antagonist treatment on the behavioral long-term potentiation and Y-maze learning performance. Neurobiol. Learn. Mem. 2014, 114:26-31. 10.1016/j.nlm.2014.04.005.
238. Liu S.-K., Fitzgerald P.B., Daigle M., Chen R., Daskalakis Z.J. The relationship between cortical inhibition, antipsychotic treatment, and the symptoms of schizophrenia. Biol. Psychiatry 2009, 65:503-509. 10.1016/j.biopsych.2008.09.012.
239. Losi G., Mariotti L., Carmignoto G. GABAergic interneuron to astrocyte signalling: a neglected form of cell communication in the brain. Philos. Trans. R. Soc. Lond. B: Biol. Sci. 2014, 369:9. 10.1098/rstb.2013.0609.
240. Luine V., Rodriguez M. Effects of estradiol on radial arm maze performance of young and aged rats. Behav. Neural Biol. 1994, 62:230-236.
241. Ma J., Leung L.S. GABA(B) receptor blockade in the hippocampus affects sensory and sensorimotor gating in Long-Evans rats. Psychopharmacology (Berl.) 2011, 217:167-176. 10.1007/s00213-011-2274-8.
242. Madsen T.M., Kristjansen P.E.G., Bolwig T.G., Wörtwein G. Arrested neuronal proliferation and impaired hippocampal function following fractionated brain irradiation in the adult rat. Neuroscience 2003, 119:635-642. 10.1016/S0306-4522(03) 00199-4.
243. Maekawa M., Namba T., Suzuki E., Yuasa S., Kohsaka S., Uchino S. NMDA receptor antagonist memantine promotes cell proliferation and production of mature granule neurons in the adult hippocampus. Neurosci. Res. 2009, 63:259-266.
244. Malenka R.C., Bear M.F. LTP and LTD an embarrassment of riches. Neuron 2004, 44:5-21.
245. Mann E.O., Kohl M.M., Paulsen O. Distinct roles of GABA(A) and GABA(B) receptors in balancing and terminating persistent cortical activity. J. Neurosci. 2009, 29:7513-7518. 10.1523/JNEUROSCI.6162-08.2009.
246. Mann E.O., Mody I. Control of hippocampal gamma oscillation frequency by tonic inhibition and excitation of interneurons. Nat. Neurosci. 2010, 13:205-212. 10.1038/nn.2464.
247. Mann J.J., Oquendo M.A., Watson K.T., Boldrini M., Malone K.M., Ellis S.P., Sullivan G., Cooper T.B., Xie S., Currier D. Anxiety in major depression and cerebrospinal fluid free gamma-aminobutyric acid. Depress. Anxiety 2014, 31:814-821. 10.1002/da.22278.
248. Markwardt S., Overstreet-Wadiche L. GABAergic signalling to adult-generated neurons. J. Physiol. 2008, 586:3745-3749. 10.1113/jphysiol.2008.155713.
249. Massone S., Vassallo I., Fiorino G., Castelnuovo M., Barbieri F., Borghi R., Tabaton M., Robello M., Gatta E., Russo C., Florio T., Dieci G., Cancedda R., Pagano A. 17A, a novel non-coding RNA, regulates GABA B alternative splicing and signaling in response to inflammatory stimuli and in Alzheimer disease. Neurobiol. Dis. 2011, 41:308-317. 10.1016/j.nbd.2010.09.019.
250. Mayordomo-Cava J., Yajeya J., Navarro-López J.D. Amyloid-β (25-35) modulates the expression of GirK and KCNQ channel genes in the hippocampus. PLoS One 2015, 10.1371/journal.pone.0134385.
251. McNamara R.K., Skelton R.W. Baclofen, a selective GABAB receptor agonist, dose-dependently impairs spatial learning in rats. Pharmacol. Biochem. Behav. 1996, 53:303-308.
252. Means L.W., Leander J.D., Isaacson R.L. The effects of hippocampectomy on alternation behavior and response of novelty. Physiol. Behav. 1971, 6:17-22.
253. Mehta U.M., Thirthalli J., Basavaraju R., Gangadhar B.N. Association of intracortical inhibition with social cognition deficits in schizophrenia: Findings from a transcranial magnetic stimulation study. Schizophr. Res. 2014, 158:146-150. 10.1016/j.schres.2014.06.043.
254. Meisler M.H. Sodium channel mutations in epilepsy and other neurological disorders. J. Clin. Invest. 2005, 115:2010-2017. 10.1172/JCI25466.
255. Meldrum B.S. Epilepsy and gamma-aminobutyric acid-mediated inhibition. Int. Rev. Neurobiol. 1975, 17:1-36.
256. Meng S., Quan W., Qi X., Su Z., Yang S. Effect of baclofen on morphine-induced conditioned place preference, extinction, and stress-induced reinstatement in chronically stressed mice. Psychopharmacology (Berl.) 2013, 10.1007/s00213-013-3204-8.
257. Merlo D., Mollinari C., Inaba Y., Cardinale A., Rinaldi A.M., D'Antuono M., D'Arcangelo G., Tancredi V., Ragsdale D., Avoli M. Reduced GABAB receptor subunit expression and paired-pulse depression in a genetic model of absence seizures. Neurobiol. Dis. 2007, 25:631-641. 10.1016/j.nbd.2006.11.005.
258. Méndez-Díaz M., Rojas S.C., Armas D.G., Ruiz-Contreras A.E., Aguilar-Roblero R., Prospéro-García O. Endocannabinoid/GABA interactions in the entopeduncular nucleus modulates alcohol intake in rats. Brain Res. Bull. 2013, 91:31-37. 10.1016/j.brainresbull.2012.11.010.
259. Milak M.S., Proper C.J., Mulhern S.T., Parter A.L., Kegeles L.S., Ogden R.T., Mao X., Rodriguez C.I., Oquendo M.A., Suckow R.F., Cooper T.B., Keilp J.G., Shungu D.C., Mann J.J. A pilot in vivo proton magnetic resonance spectroscopy study of amino acid neurotransmitter response to ketamine treatment of major depressive disorder. Mol. Psychiatry 2015, 10.1038/mp.2015.83.
260. Misgeld U., Bijak M., Jarolimek W. A physiological role for GABAB receptors and the effects of baclofen in the mammalian central nervous system. Prog. Neurobiol. 1995, 46:423-462.
261. Mitchell S.J., Rawlins J.N., Steward O., Olton D.S. Medial septal area lesions disrupt theta rhythm and cholinergic staining in medial entorhinal cortex and produce impaired radial arm maze behavior in rats. J. Neurosci. 1982, 2:292-302.
262. Miyamoto M., Shintani M., Nagaoka A., Nagawa Y. Lesioning of the rat basal forebrain leads to memory impairments in passive and active avoidance tasks. Brain Res. 1985, 328:97-104. 10.1016/0006-8993(85) 91327-7.
263. Mizukami K., Ishikawa M., Hidaka S., Iwakiri M., Sasaki M., Iritani S. Immunohistochemical localization of GABAB receptor in the entorhinal cortex and inferior temporal cortex of schizophrenic brain. Prog. Neuropsychopharmacol. Biol. Psychiatry 2002, 26:393-396.
264. Mizukami K., Sasaki M., Ishikawa M., Iwakiri M., Hidaka S., Shiraishi H., Iritani S. Immunohistochemical localization of γ-aminobutyric acid B receptor in the hippocampus of subjects with schizophrenia. Neurosci. Lett. 2000, 283:101-104.
265. Mokrushin A.A., Khama-Murad A.K., Semenova O.G., Shalyapina V.G. Electrophysiological characteristics of depressive states in rats with passive strategies of adaptive behavior. Neurosci. Behav. Physiol. 2009, 39:275-280. 10.1007/s11055-009-9133-7.
266. Mondadori C., Jaekel J., Preiswerk G. CGP 36742: The first orally active GABAB blocker improves the cognitive performance of mice, rats, and rhesus monkeys. Behav. Neural Biol. 1993, 60:62-68. 10.1016/0163-1047(93) 90729-2.
267. Mondadori C., Moebius H.J., Zingg M. CGP 36742, an orally active GABAB receptor antagonist, facilitates memory in a social recognition test in rats. Behav. Brain Res. 1996, 77:227-229.
268. Mondadori C., Möbius H.J., Borkowski J. The GABAB receptor antagonist CGP 36,742 and the nootropic oxiracetam facilitate the formation of long-term memory. Behav. Brain Res. 1996, 77:223-225.
269. Montero-Pastor A., Vale-Martínez A., Guillazo-Blanch G., Martí-Nicolovius M. Effects of electrical stimulation of the nucleus basalis on two-way active avoidance acquisition, retention, and retrieval. Behav. Brain Res. 2004, 154:41-54. 10.1016/j.bbr.2004.01.017.
270. Morgan M.A., LeDoux J.E. Differential contribution of dorsal and ventral medial prefrontal cortex to the acquisition and extinction of conditioned fear in rats. Behav. Neurosci. 1995, 109:681-688.
271. Morris R.G.M., Garrud P., Rawlins J.N., O'Keefe J. Place navigation impaired in rats with hippocampal lesions. Nature 1982, 297:681-683.
272. Morrisett R.A., Mott D.D., Lewis D.V., Swartzwelder H.S., Wilson W.A. GABAB-receptor-mediated inhibition of the N-methyl-d-aspartate component of synaptic transmission in the rat hippocampus. J. Neurosci. 1991, 11:203-209.
273. Mott D.D., Lewis D.V. GABAB receptors mediate disinhibition and facilitate long-term potentiation in the dentate gyrus. Epilepsy Res. Suppl. 1992, 7:119-134.
274. Mott D.D., Lewis D.V. Facilitation of the induction of long-term potentiation by GABAB receptors. Science 1991, 252:1718-1720.
275. Mott D.D., Lewis D.V., Ferrari C.M., Wilson W.A., Swartzwelder H.S. Baclofen facilitates the development of long-term potentiation in the rat dentate gyrus. Neurosci. Lett. 1990, 113:222-226.
276. Mott D.D., Xie C.W., Wilson W.A., Swartzwelder H.S., Lewis D.V. GABAB autoreceptors mediate activity-dependent disinhibition and enhance signal transmission in the dentate gyrus. J. Neurophysiol. 1993, 69:674-691. 10.1080/10723030902991076.
277. Moyer J.R., Deyo R.A., Disterhoft J.F. Hippocampectomy disrupts trace eye-blink conditioning in rabbits. Behav. Neurosci. 1990, 104:243-252.
278. Muñoz A., Arellano J.I., DeFelipe J. GABABR1 receptor protein expression in human mesial temporal cortex: changes in temporal lobe epilepsy. J. Comp. Neurol. 2002, 449:166-179. 10.1002/cne.10287.
279. Murray C.L., Fibiger H.C. Pilocarpine and physostigmine attenuate spatial memory impairments produced by lesions of the nucleus basalis magnocellularis. Behav. Neurosci. 1986, 100:23-32.
280. Nakagawa Y., Ishibashi Y., Yoshii T., Tagashira E. Involvement of cholinergic systems in the deficit of place learning in Morris water maze task induced by baclofen in rats. Brain Res. 1995, 683:209-214.
281. Nakagawa Y., Iwasaki T., Ishima T., Kimura K. Interaction between benzodiazepine and GABA-A receptors in state-dependent learning. Life Sci. 1993, 52:1935-1945. 10.1016/0024-3205(93) 90634-F.
282. Nakagawa Y., Takashima T. The GABA B receptor antagonist CGP36742 attenuates the baclofen-and scopolamine-induced deficit in Morris water maze task in rats. Brain Res. 1997, 766:101-106.
283. Nava-Mesa M.O., Jiménez-Díaz L., Yajeya J., Navarro-Lopez J.D. Amyloid-β induces synaptic dysfunction through G protein-gated inwardly rectifying potassium channels in the fimbria-CA3 hippocampal synapse. Front. Cell. Neurosci. 2013, 7:117. 10.3389/fncel.2013.00117.
284. Nilsson M., Perfilieva E., Johansson U., Orwar O., Eriksson P.S. Enriched environment increases neurogenesis in the adult rat dentate gyrus and improves spatial memory. J. Neurobiol. 1999, 39:569-578.
285. Nunan R., Sivasathiaseelan H., Khan D., Zaben M., Gray W. Microglial VPAC1R mediates a novel mechanism of neuroimmune-modulation of hippocampal precursor cells via IL-4 release. Glia 2014, 10.1002/glia.22682.
286. Oblak A.L., Gibbs T.T., Blatt G.J. Reduced GABAA receptors and benzodiazepine binding sites in the posterior cingulate cortex and fusiform gyrus in autism. Brain Res. 2011, 1380:218-228. 10.1016/j.brainres.2010.09.021.
287. Oblak A.L., Gibbs T.T., Blatt G.J. Decreased GABA(B) receptors in the cingulate cortex and fusiform gyrus in autism. J. Neurochem. 2010, 114:1414-1423. 10.1111/j.1471-4159.2010.06858.x.
288. Olpe H.-R., Steinmann M.W., Ferrat T., Pozza M.F., Greiner K., Brugger F., Froestl W., Mickel S.J., Bittiger H. The actions of orally active GABAB receptor antagonists on GABAergic transmission in vivo and in vitro. Eur. J. Pharmacol. 1993, 233:179-186.
289. Olton D.S., Isaacson R.L. Hippocampal lesions and active avoidance. Physiol. Behav. 1968, 3:719-724. 10.1016/0031-9384(68) 90142-X.
290. Olvera-Cortes E., Cervantes M., Gonzalez-Burgos I. Place-learning, but not cue-learning training, modifies the hippocampal theta rhythm in rats. Brain Res. Bull. 2002, 58:261-270.
291. Ong J., Bexis S., Marino V., Parker D.A., Kerr D.I.B., Froestl W. Comparative activities of the enantiomeric GABA(B) receptor agonists CGP 44532 and 44533 in central and peripheral tissues. Eur. J. Pharmacol. 2001, 412:27-37. 10.1016/S0014-2999(00) 00945-6.
292. Ong J., Kerr D.I.B. Clinical potential of GABAB receptor modulators. CNS Drug Rev. 2005, 11:317-334.
293. Orr G., Rao G., Houston F.P., McNaughton B.L., Barnes C.A. Hippocampal synaptic plasticity is modulated by theta rhythm in the fascia dentata of adult and aged freely behaving rats. Hippocampus 2001, 11:647-654. 10.1002/hipo.1079.
294. Orrù A., Fujani D., Cassina C., Conti M., Di Clemente A., Cervo L. Operant, oral alcoholic beer self-administration by C57BL/6 J mice: effect of BHF177, a positive allosteric modulator of GABAB receptors. Psychopharmacology (Berl.) 2012, 222:685-700.
295. Ort A., Kometer M., Rohde J., Seifritz E., Vollenweider F.X. The role of GABAB receptors in human reinforcement learning. Eur. Neuropsychopharmacol. 2014, 24:1606-1614. 10.1016/j.euroneuro.2014.08.013.
296. Ostrovskaya O., Xie K., Masuho I., Fajardo-Serrano A., Lujan R., Wickman K., Martemyanov K.A., Aldrich R. RGS7/Gβ5/R7BP complex regulates synaptic plasticity and memory by modulating hippocampal GABABR-GIRK signaling. Life Sci. 2014, 3:e02053. 10.7554/eLife.02053.
297. Öngür D., Prescot A.P., McCarthy J., Cohen B.M., Renshaw P.F. Elevated gamma-aminobutyric acid levels in chronic schizophrenia. Biol. Psychiatry 2010, 68:667-670. 10.1016/j.biopsych.2010.05.016.
298. Padgett C.L., Slesinger P.A. GABAB receptor coupling to G-proteins and ion channels. Adv. Pharmacol. 2010, 58:123-147. 10.1016/S1054-3589(10) 58006-2.
299. Page K.J., Everitt B.J., Robbins T.W., Marston H.M., Wilkinson L.S. Dissociable effects on spatial maze and passive avoidance acquisition and retention following ampa- and ibotenic acid-induced excitotoxic lesions of the basal forebrain in rats: differential dependence on cholinergic neuronal loss. Neuroscience 1991, 10.1016/0306-4522(91) 90308-B.
300. Paolicelli R.C., Bolasco G., Pagani F., Maggi L., Scianni M., Panzanelli P., Giustetto M., Ferreira T.A., Guiducci E., Dumas L., Ragozzino D., Gross C.T. Synaptic pruning by microglia is necessary for normal brain development. Science 2011, 333:1456-1458. 10.1126/science.1202529.
301. Parkhurst C.N., Yang G., Ninan I., Savas J.N., Yates J.R., Lafaille J.J., Hempstead B.L., Littman D.R., Gan W.-B. Microglia promote learning-dependent synapse formation through brain-derived neurotrophic factor. Cell 2013, 155:1596-1609. 10.1016/j.cell.2013.11.030.
302. Patenaude C., Chapman C.A., Bertrand S., Congar P., Lacaille J.-C. GABAB receptor- and metabotropic glutamate receptor-dependent cooperative long-term potentiation of rat hippocampal GABAA synaptic transmission. J. Physiol. 2003, 553:155-167. 10.1113/jphysiol.2003.049015.
303. Patenaude C., Massicotte G., Lacaille J.-C. Cell-type specific GABA synaptic transmission and activity-dependent plasticity in rat hippocampal stratum radiatum interneurons. Eur. J. Neurosci. 2005, 22:179-188. 10.1111/j. 1460-9568.2005.04207.x.
304. Pavlides C., Greenstein Y.J., Grudman M., Winson J. Long-term potentiation in the dentate gyrus is induced preferentially on the positive phase of theta-rhythm. Brain Res. 1988, 439:383-387.
305. Paylor R., Zhao Y., Libbey M., Westphal H., Crawley J.N. Learning impairments and motor dysfunctions in adult Lhx5-deficient mice displaying hippocampal disorganization. Physiol. Behav. 2001, 73:781-792. 10.1016/S0031-9384(01)00515-7.
306. Perry W., Minassian A., Lopez B., Maron L., Lincoln A. Sensorimotor gating deficits in adults with autism. Biol. Psychiatry 2007, 61(February (4)):482-486.
307. 2+ spikes in layer 5 somatosensory pyramidal neurons. Neuron 2006, 50:603-616. 10.1016/j.neuron.2006.04.019.
308. Phillips R., LeDoux J.E. Differential contribution of amygdala and hippocampus to cued and contextual fear conditioning. Behav. Neurosci. 1992, 106:274-285.
309. Pirttimaki T., Parri H.R., Crunelli V. Astrocytic GABA transporter GAT-1 dysfunction in experimental absence seizures. J. Physiol. 2013, 591:823-833. 10.1113/jphysiol.2012.242016.
310. Pitsikas N., Rigamonti A.E., Cella S.G., Muller E.E. The GABAB receptor and recognition memory: possible modulation of its behavioral effects by the nitrergic system. Neuroscience 2003, 118:1121-1127. 10.1016/S0306-4522(03) 00067-8.
311. Pontes A., Zhang Y., Hu W. Novel functions of GABA signaling in adult neurogenesis. Front. Biol. 2013, 8. 10.1007/s11515-013-1270-2.
312. Porter M.C., Burk J.A., Mair R.G. A comparison of the effects of hippocampal or prefrontal cortical lesions on three versions of delayed non-matching-to-sample based on positional or spatial cues. Behav. Brain Res. 2000, 109:69-81. 10.1016/S0166-4328(99) 00161-8.
313. Premoli I., Rivolta D., Espenhahn S., Castellanos N., Belardinelli P., Ziemann U., Müller-Dahlhaus F. Characterization of GABAB-receptor mediated neurotransmission in the human cortex by paired-pulse TMS-EEG. Neuroimage 2014, 103C:152-162. 10.1016/j.neuroimage.2014.09.028.
314. Princivalle A.P., Duncan J.S., Thom M., Bowery N.G. GABA (B1a), GABA (B1b) AND GABA (B2) mRNA variants expression in hippocampus resected from patients with temporal lobe epilepsy. Neuroscience 2003, 122:975.
315. Princivalle A.P., Richards D.A., Duncan J.S., Spreafico R., Bowery N.G. Modification of GABAB1 and GABAB2 receptor subunits in the somatosensory cerebral cortex and thalamus of rats with absence seizures (GAERS). Epilepsy Res. 2003, 55:39-51. 10.1016/S0920-1211(03) 00090-1.
316. Raber J., Rola R., LeFevour A., Morhardt D., Curley J., Mizumatsu S., VandenBerg S.R., Fike J.R. Radiation-induced cognitive impairments are associated with changes in indicators of hippocampal neurogenesis. Radiat. Res. 2004, 162:39-47.
317. Rajalu M., Fritzius T., Adelfinger L., Jacquier V., Besseyrias V., Gassmann M., Bettler B. Pharmacological characterization of GABAB receptor subtypes assembled with auxiliary KCTD subunits. Neuropharmacology 2015, 88:145-154. 10.1016/j.neuropharm.2014.08.020.
318. Rashidy-Pour A., Motamedi F., Motahed-Larijani Z. Effects of reversible inactivations of the medial septal area on reference and working memory versions of the Morris water maze. Brain Res. 1996, 709:131-140.
319. Redish A.D., Touretzky D.S. The role of the hippocampus in solving the Morris water maze. Neural Comput. 1998, 10:73-111.
320. Reilly S. The parabrachial nucleus and conditioned taste aversion. Brain Res. Bull. 1999, 48:239-254.
321. Reilly S., Harley C., Revusky S. Ibotenate lesions of the hippocampus enhance latent inhibition in conditioned taste aversion and increase resistance to extinction in conditioned taste preference. Behav. Neurosci. 1993, 107:996-1004.
322. Remondes M., Schuman E.M. Role for a cortical input to hippocampal area CA1 in the consolidation of a long-term memory. Nature 2004, 431:699-703. 10.1038/nature02965.
323. Remondes M., Schuman E.M. Molecular mechanisms contributing to long-lasting synaptic plasticity at the temporoammonic-CA1 synapse. Learn. Mem. 2003, 10:247-252. 10.1101/lm.59103.
324. Reshef R., Kreisel T., Kay D.B., Yirmiya R. Microglia and their CX3CR1 signaling are involved in hippocampal- but not olfactory bulb-related memory and neurogenesis. Brain Behav. Immun. 2014, 41:239-250. 10.1016/j.bbi.2014.04.009.
325. Reuveny E. Structural biology: Ion channel twists to open. Nature 2013, 498:182-183. 10.1038/nature12255.
326. Riazi K., Galic M.A., Kuzmiski J.B., Ho W., Sharkey K.A., Pittman Q.J. Microglial activation and TNFalpha production mediate altered CNS excitability following peripheral inflammation. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:17151-17156. 10.1073/pnas.0806682105.
327. Riedel G., Platt B., Micheau J. Glutamate receptor function in learning and memory. Behav. Brain Res. 2003, 140:1-47.
328. Robinson R., Taske N., Sander T., Heils A., Whitehouse W., Goutières F., Aicardi J., Lehesjoki A.E., Siren A., Laue Friis M., Kjeldsen M.J., Panayiotopoulos C., Kennedy C., Ferrie C., Rees M., Gardiner R.M. Linkage analysis between childhood absence epilepsy and genes encoding GABAA and GABAB receptors voltage-dependent calcium channels, and the ECA1 region on chromosome 8q. Epilepsy Res. 2002, 48:169-179.
329. Roenker N.L., Gudelsky G.A., Ahlbrand R., Horn P.S., Richtand N.M. Evidence for involvement of nitric oxide and GABA(B) receptors in MK-801- stimulated release of glutamate in rat prefrontal cortex. Neuropharmacology 2012, 63:575-581. 10.1016/j.neuropharm.2012.04.032.
330. Rogasch N.C., Daskalakis Z.J., Fitzgerald P.B. Cortical inhibition of distinct mechanisms in the dorsolateral prefrontal cortex is related to working memory performance: a TMS-EEG study. Cortex 2014, 64C:68-77. 10.1016/j.cortex.2014.10.003.
331. Roldan G., Bures J. Tetrodotoxin blockade of amygdala overlapping with poisoning impairs acquisition of conditioned taste aversion in rats. Behav. Brain Res. 1994, 65:213-219. 10.1016/0166-4328(94) 90107-4.
332. Romanides A.J., Duffy P., Kalivas P.W. Glutamatergic and dopaminergic afferents to the prefrontal cortex regulate spatial working memory in rats. Neuroscience 1999, 92:97-106. 10.1016/S0306-4522(98) 00747-7.
333. Rost B.R., Nicholson P., Ahnert-Hilger G., Rummel A., Rosenmund C., Breustedt J., Schmitz D. Activation of metabotropic GABA receptors increases the energy barrier for vesicle fusion. J. Cell Sci. 2011, 124:3066-3073. 10.1242/jcs.074963.
334. Rutishauser U., Ross I.B., Mamelak A.N., Schuman E.M. Human memory strength is predicted by theta-frequency phase-locking of single neurons. Nature 2010, 464:903-907. 10.1038/nature08860.
335. Sabbagh M.N. Drug development for Alzheimer's disease: where are we now and where are we headed?. Am. J. Geriatr. Pharmacother. 2009, 7:167-185.
336. Saha N., Chugh Y., Sankaranaryanan A., Sharma P.L. Effects of post-training administration of (-)-baclofen and chlordiazepoxide on memory retention in ICRC Swiss mice: interactions with GABAA and GABAB receptor antagonists. Pharmacol. Toxicol. 1993, 72:159-162.
337. Sakaba T., Neher E. Direct modulation of synaptic vesicle priming by GABA(B) receptor activation at a glutamatergic synapse. Nature 2003, 424:775-778. 10.1038/nature01859.
338. Sanders H., Berends M., Major G., Goldman M.S., Lisman J.E. NMDA and GABAB (KIR) conductances: the perfect couple for bistability. J. Neurosci. 2013, 33:424-429. 1854-12.2013. 10.1523/JNEUROSCI.
339. Saxe M.D., Battaglia F., Wang J.W., Malleret G., David D.J., Monckton J.E., Garcia A.D.R., Sofroniew M.V., Kandel E.R., Santarelli L., Hen R., Drew M.R. Ablation of hippocampal neurogenesis impairs contextual fear conditioning and synaptic plasticity in the dentate gyrus. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:17501-17506. 10.1073/pnas.0607207103.
340. Scanziani M. GABA spillover activates postsynaptic GABA(B) receptors to control rhythmic hippocampal activity. Neuron 2000, 25:673-681. 10.1016/S0896-6273(00) 81069-7.
341. Schuler V., Lüscher C., Blanchet C., Klix N., Sansig G., Klebs K., Schmutz M., Heid J., Gentry C., Urban L., Fox A., Spooren W.P.J.M., Jaton A.L., Vigouret J., Pozza M.F., Kelly P.H., Mosbacher J., Froestl W., Käslin E., Korn R., Bischoff S., Kaupmann K., van der Putten H., Bettler B. Epilepsy, hyperalgesia, impaired memory, and loss of pre- and postsynaptic GABA(B) responses in mice lacking GABA(B(1)). Neuron 2001, 31:47-58.
342. Schwab C., Yu S., Wong W., McGeer E.G., McGeer P.L. GAD65, GAD67, and GABAT immunostaining in human brain and apparent GAD65 loss in Alzheimer's disease. J. Alzheimers Dis. 2013, 33:1073-1088. 10.3233/JAD-2012-121330.
343. Schwenk J., Metz M., Zolles G., Turecek R., Fritzius T., Bildl W., Tarusawa E., Kulik A., Unger A., Ivankova K., Seddik R., Tiao J.Y., Rajalu M., Trojanova J., Rohde V., Gassmann M., Schulte U., Fakler B., Bettler B. Native GABA(B) receptors are heteromultimers with a family of auxiliary subunits. Nature 2010, 465:231-235. 10.1038/nature08964.
344. Schwenk J., Pérez-Garci E., Schneider A., Kollewe A., Gauthier-Kemper A., Fritzius T., Raveh A., Dinamarca M.C., Hanuschkin A., Bildl W., Klingauf J., Gassmann M., Schulte U., Bettler B., Fakler B. Modular composition and dynamics of native GABAB receptors identified by high-resolution proteomics. Nat. Neurosci. 2015, 10.1038/nn.4198.
345. Seddik R., Jungblut S.P., Silander O.K., Rajalu M., Fritzius T., Besseyrias V., Jacquier V., Fakler B., Gassmann M., Bettler B. Opposite effects of KCTD subunit domains on GABA(B) receptor-mediated desensitization. J. Biol. Chem. 2012, 287:39869-39877. 10.1074/jbc.M112.412767.
346. Sederberg P.B., Schulze-Bonhage A., Madsen J.R., Bromfield E.B., McCarthy D.C., Brandt A., Tully M.S., Kahana M.J. Hippocampal and neocortical gamma oscillations predict memory formation in humans. Cereb. Cortex 2007, 17:1190-1196. 10.1093/cercor/bhl030.
347. Seidl R., Cairns N., Singewald N., Kaehler S.T., Lubec G. Differences between GABA levels in Alzheimer's disease and Down syndrome with Alzheimer-like neuropathology. Naunyn Schmiedebergs Arch. Pharmacol. 2001, 363:139-145.
348. Serrano A., Haddjeri N., Lacaille J.-C., Robitaille R. GABAergic network activation of glial cells underlies hippocampal heterosynaptic depression. J. Neurosci. 2006, 26:5370-5382. 5255-05.2006. 10.1523/JNEUROSCI.
349. Setlow B., McGaugh J.L. Involvement of the posteroventral caudate-putamen in memory consolidation in the Morris water maze. Neurobiol. Learn. Mem. 1999, 71:240-247. 10.1006/nlme.1998.3874.
350. Seymoure P., Dou H., Juraska J.M. Sex differences in radial maze performance: influence of rearing environment and room cues. Psychobiology 1996, 24(March (1)):33-37.
351. Shaban H., Humeau Y., Herry C., Cassasus G., Shigemoto R., Ciocchi S., Barbieri S., van der Putten H., Kaupmann K., Bettler B., Lüthi A. Generalization of amygdala LTP and conditioned fear in the absence of presynaptic inhibition. Nat. Neurosci. 2006, 9:1028-1035. 10.1038/nn1732.
352. Shahrzad P., Nasser N. GABAb receptor antagonist (CGP35348) improves testosterone induced spatial acquisition impairment in adult male rat. JBBS 2015, 05:491-502. 10.4236/jbbs.2015.511047.
353. Sharma A.C., Kulkarni S.K. (+/-) Baclofen sensitive scopolamine-induced short-term memory deficits in mice. Indian J. Exp. Biol. 1993, 31:348-352.
354. Shin R., Ikemoto S. The GABAB receptor agonist baclofen administered into the median and dorsal raphe nuclei is rewarding as shown by intracranial self-administration and conditioned place preference in rats. Psychopharmacology (Berl.) 2010, 208:545-554. 10.1007/s00213-009-1757-3.
355. Shors T.J., Miesegaes G., Beylin A., Zhao M., Rydel T., Gould E. Neurogenesis in the adult is involved in the formation of trace memories. Nature 2001, 410:372-376. 10.1038/35066584.
356. Sibille E., Wang Y., Joeyen-Waldorf J., Gaiteri C., Surget A., Oh S., Belzung C., Tseng G.C., Lewis D.A. A molecular signature of depression in the amygdala. Am. J. Psychiatry 2009, 166:1011-1024. 10.1176/appi.ajp.2009.08121760.
357. Sidel E.S., Tilson H.A., McLamb R.L., Wilson W.A., Swartzwelder H.S. Potential interactions between GABAb and cholinergic systems: baclofen augments scopolamine-induced performance deficits in the eight-arm radial maze. Psychopharmacology (Berl.) 1988, 96:116-120.
358. Sierra A., Encinas J.M., Deudero J.J.P., Chancey J.H., Enikolopov G., Overstreet-Wadiche L.S., Tsirka S.E., Maletic-Savatic M. Microglia shape adult hippocampal neurogenesis through apoptosis-coupled phagocytosis. Cell Stem Cell 2010, 7:483-495. 10.1016/j.stem.2010.08.014.
359. Silverman J.L., Pride M.C., Hayes J.E., Puhger K.R., Butler-Struben H.M., Baker S., Crawley J.N. GABAB receptor agonist R-baclofen reverses social deficits and reduces repetitive behavior in two mouse models of autism. Neuropsychopharmacology 2015, 40:2228-2239. 10.1038/npp.2015.66.
360. Slattery D.A., Cryan J.F. The role of GABAB receptors in depression and antidepressant-related behavioural responses. Drug Dev. Res. 2006, 67:477-494. 10.1002/ddr.20110.
361. Smith G.K., Kesner R.P., Korenberg J.R. Dentate gyrus mediates cognitive function in the Ts65Dn/DnJ mouse model of Down syndrome. Hippocampus 2013, 24(March (3)):354-362. 10.1002/hipo.22229.
362. Snead O.C., Cortez M.A., Francis J., Eubanks J.H. GABAB receptor gene expression is altered in an animal model of atypical absence epilepsy. Epilepsia 2000, 41. 1-256. 10.1111/j.1528-1157.2000.tb01727.x.
363. Sotres-Bayon F., Cain C.K., LeDoux J.E. Brain mechanisms of fear extinction: historical perspectives on the contribution of prefrontal cortex. Biol. Psychiatry 2006, 60:329-336. 10.1016/j.biopsych.2005.10.012.
364. Spano M.S., Fattore L., Fratta W., Fadda P. The GABAB receptor agonist baclofen prevents heroin-induced reinstatement of heroin-seeking behavior in rats. Neuropharmacology 2007, 52:1555-1562. 10.1016/j.neuropharm.2007.02.012.
365. Stackman R.W., Walsh T.J. Baclofen produces dose-related working memory impairments after intraseptal injection. Behav. Neural Biol. 1994, 61:181-185. 10.1016/S0163-1047(05) 80073-1.
366. Staubli U.V., Scafidi J., Chun D. GABAB receptor antagonism: facilitatory effects on memory parallel those on LTP induced by TBS but not HFS. J. Neurosci. 1999, 19:4609.
367. Steketee J.D., Beyer C.E. Injections of baclofen into the ventral medial prefrontal cortex block the initiation, but not the expression, of cocaine sensitization in rats. Psychopharmacology (Berl.) 2005, 180:352-358. 10.1007/s00213-005-2149-y.
368. Stepan J., Dine J., Fenzl T., Polta S.A., Wolff von G., Wotjak C.T., Eder M. Entorhinal theta-frequency input to the dentate gyrus trisynaptically evokes hippocampal CA1 LTP. Front Neural Circuits 2012, 6. 10.3389/fncir.2012.00064.
369. Stewart L.S., Wu Y., Eubanks J.H., Han H., Leschenko Y., Perez Velazquez J.L., Cortez M.A., Snead O.C. Severity of atypical absence phenotype in GABAB transgenic mice is subunit specific. Epilepsy Behav. 2009, 14:577-581. 10.1016/j.yebeh.2009.01.019.
370. Straessle A., Loup F., Arabadzisz D., Ohning G.V., Fritschy J.-M. Rapid and long-term alterations of hippocampal GABAB receptors in a mouse model of temporal lobe epilepsy. Eur. J. Neurosci. 2003, 18:2213-2226.
371. Stuchlik A., Vales K. Baclofen dose-dependently disrupts learning in a place avoidance task requiring cognitive coordination. Physiol. Behav. 2009, 97:507-511. 10.1016/j.physbeh.2009.03.024.
372. Sun B., Halabisky B., Zhou Y., Palop J.J., Yu G., Mucke L., Gan L. Imbalance between GABAergic and glutamatergic transmission impairs adult neurogenesis in an animal model of Alzheimer's disease. Cell Stem Cell 2009, 5:624-633. 10.1016/j.stem.2009.10.003.
373. Sunyer B., An G., Kang S.U., Höger H., Lubec G. Strain-dependent hippocampal protein levels of GABA B-receptor subunit 2 and NMDA-receptor subunit 1. Neurochem. Int. 2009, 55:253-256.
374. Sunyer B., Patil S., Frischer C., Höger H., Selcher J., Brannath W., Lubec G. Strain-dependent effects of SGS742 in the mouse. Behav. Brain Res. 2007, 181:64-75. 10.1016/j.bbr.2007.03.025.
375. Sunyer B., Shim K.-S., An G., Höger H., Lubec G. Hippocampal levels of phosphorylated protein kinase a (phosphor-S96) are linked to spatial memory enhancement by SGS742. Hippocampus 2009, 19:90-98. 10.1002/hipo.20484.
376. Sutherland R.J., Kolb B., Whishaw I.Q. Spatial mapping: definitive disruption by hippocampal or medial frontal cortical damage in the rat. Neurosci. Lett. 1982, 31(August (3)):271-276.
377. Sutherland R.J., Whishaw I.Q., Kolb B. A behavioural analysis of spatial localization following electrolytic, kainate- or colchicine-induced damage to the hippocampal formation in the rat. Behav. Brain Res. 1983, 7:133-153.
378. Swartzwelder H.S., Tilson H.A., McLamb R.L., Wilson W.A. Baclofen disrupts passive avoidance retention in rats. Psychopharmacology (Berl.) 1987, 92:398-401.
379. Tanaka S., Ide M., Shibutani T., Ohtaki H., Numazawa S., Shioda S., Yoshida T. Lipopolysaccharide-induced microglial activation induces learning and memory deficits without neuronal cell death in rats. J. Neurosci. Res. 2006, 83:557-566. 10.1002/jnr.20752.
380. Tanaka S., Kondo H., Kanda K., Ashino T., Nakamachi T., Sekikawa K., Iwakura Y., Shioda S., Numazawa S., Yoshida T. Involvement of interleukin-1 in lipopolysaccaride-induced microglial activation and learning and memory deficits. J. Neurosci. Res. 2011, 89:506-514. 10.1002/jnr.22582.
381. Tang Y.P., Shimizu E., Dube G.R., Rampon C., Kerchner G.A., Zhuo M., Liu G., Tsien J.Z. Genetic enhancement of learning and memory in mice. Nature 1999, 401:63-69. 10.1038/43432.
382. Tao W., Higgs M.H., Spain W.J., Ransom C.B. Postsynaptic GABAB receptors enhance extrasynaptic gabaa receptor function in dentate gyrus granule cells. J. Neurosci. 2013, 33:3738-3743. 4829-12.2013. 10.1523/JNEUROSCI.
383. Teichgräber L.A., Lehmann T.N., Meencke H.J., Weiss T., Nitsch R., Deisz R.A. Impaired function of GABAB receptors in tissues from pharmacoresistant epilepsy patients. Epilepsia 2009, 50:1697-1716.
384. Terunuma M., Haydon P.G., Pangalos M.N., Moss S.J. Purinergic receptor activation facilitates astrocytic GABAB receptor calcium signalling. Neuropharmacology 2015, 88:74-81. 10.1016/j.neuropharm.2014.09.015.
385. Terunuma M., Revilla-Sanchez R., Quadros I.M., Deng Q., Deeb T.Z., Lumb M., Sicinski P., Haydon P.G., Pangalos M.N., Moss S.J. Postsynaptic GABAB receptor activity regulates excitatory neuronal architecture and spatial memory. J. Neurosci. 2014, 34:804-816. 3320-13.2013. 10.1523/JNEUROSCI.
386. Terunuma M., Vargas K.J., Wilkins M.E., Ramírez O.A., Jaureguiberry-Bravo M., Pangalos M.N., Smart T.G., Moss S.J., Couve A. Prolonged activation of NMDA receptors promotes dephosphorylation and alters postendocytic sorting of GABAB receptors. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:13918-13923. 10.1073/pnas.1000853107.
387. Thatcher R.W., North D.M., Neubrander J., Biver C.J., Cutler S., Defina P. Autism and EEG phase reset: deficient GABA mediated inhibition in thalamo-cortical circuits. Dev. Neuropsychol. 2009, 34:780-800. 10.1080/87565640903265178.
388. Tiao J.Y., Bradaia A., Biermann B., Kaupmann K., Metz M., Haller C., Rolink A.G., Pless E., Barlow P.N., Gassmann M., Bettler B. The sushi domains of secreted GABAB1 isoforms selectively impair GABAB heteroreceptor function. J. Biol. Chem. 2008, 283:31005-31011. 10.1074/jbc.M804464200.
389. Torrey E.F., Barci B.M., Webster M.J., Bartko J.J., Meador-Woodruff J.H., Knable M.B. Neurochemical markers for schizophrenia, bipolar disorder, and major depression in postmortem brains. Biol. Psychiatry 2005, 57:252-260. 10.1016/j.biopsych.2004.10.019.
390. Tort A.B.L., Komorowski R.W., Manns J.R., Kopell N.J., Eichenbaum H. Theta-gamma coupling increases during the learning of item-context associations. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:20942-20947. 10.1073/pnas.0911331106.
391. Traub R.D. GABA-enhanced collective behavior in neuronal axons underlies persistent gamma-frequency oscillations. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:11047-11052. 10.1073/pnas.1934854100.
392. Tremblay M.-E., Lowery R.L., Majewska A.K. Microglial interactions with synapses are modulated by visual experience. PLoS Biol. 2010, 8:e1000527. 10.1371/journal.pbio.1000527.
393. Tremblay M.-E., Stevens B., Sierra A., Wake H., Bessis A., Nimmerjahn A. The role of microglia in the healthy brain. J. Neurosci. 2011, 31:16064-16069. 4158-11.2011. 10.1523/JNEUROSCI.
394. Turecek R., Schwenk J., Fritzius T., Ivankova K., Zolles G., Adelfinger L., Jacquier V., Besseyrias V., Gassmann M., Schulte U., Fakler B., Bettler B. Auxiliary GABAB receptor subunits uncouple g protein βγsubunits from effector channels to induce desensitization. Neuron 2014, 10.1016/j.neuron.2014.04.015.
395. Tzschentke T.M. Measuring reward with the conditioned place preference (CPP) paradigm: update of the last decade. Addict. Biol. 2007, 12:227-462. 10.1111/j. 1369-1600.2007.00070.x.
396. Uehara T., Sumiyoshi T., Hattori H., Itoh H., Matsuoka T., Iwakami N., Suzuki M., Kurachi M. T-817MA, a novel neurotrophic agent, ameliorates loss of GABAergic parvalbumin-positive neurons and sensorimotor gating deficits in rats transiently exposed to MK-801 in the neonatal period. J. Psychiatr. Res. 2012, 46:622-629. 10.1016/j.jpsychires.2012.01.022.
397. Uekita T., Okanoya K. Hippocampus lesions induced deficits in social and spatial recognition in Octodon degus. Behav. Brain Res. 2011, 219:302-309.
398. Upchurch M., Wehner J.M. Differences between inbred strains of mice in Morris water maze performance. Behav. Genet. 1988, 18:55-68. 10.1007/BF01067075.
399. Urwyler S., Mosbacher J., Lingenhoehl K., Heid J., Hofstetter K., Froestl W., Bettler B., Kaupmann K. Positive allosteric modulation of native and recombinant γ-aminobutyric acidb receptors by 2,6-di-tert-butyl-4-(3-hydroxy-2,2-dimethyl-propyl)-phenol (CGP7930) and its aldehyde analog CGP13501. Mol. Pharmacol. 2001, 60:963-971.
400. Urwyler S., Pozza M.F., Lingenhoehl K., Mosbacher J., Lampert C., Froestl W., Koller M., Kaupmann K. N,N'-Dicyclopentyl-2-methylsulfanyl-5-nitro-pyrimidine-4, 6-diamine (GS39783) and structurally related compounds: novel allosteric enhancers of gamma-aminobutyric acidB receptor function. J. Pharmacol. Exp. Ther. 2003, 307:322-330. 10.1124/jpet.103.053074.
401. Van der Borght K., Meerlo P., Luiten P.G.M., Eggen B.J.L., Van der Zee E.A. Effects of active shock avoidance learning on hippocampal neurogenesis and plasma levels of corticosterone. Behav. Brain Res. 2005, 157:23-30. 10.1016/j.bbr.2004.06.004.
402. van Praag H., Christie B.R., Sejnowski T.J., Gage F.H. Running enhances neurogenesis, learning, and long-term potentiation in mice. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:13427-13431.
403. van Praag H., Kempermann G., Gage F.H. Running increases cell proliferation and neurogenesis in the adult mouse dentate gyrus. Nat. Neurosci. 1999, 2:266-270. 10.1038/6368.
404. Varani A.P., Aso E., Maldonado R., Balerio G.N. Baclofen and 2-hydroxysaclofen modify acute hypolocomotive and antinociceptive effects of nicotine. Eur. J. Pharmacol. 2014, 738C:200-205. 10.1016/j.ejphar.2014.05.039.
405. Varani A.P., Pedrón V.T., Machado L.M., Antonelli M.C., Bettler B., Balerio G.N. Lack of GABAB receptors modifies behavioural and biochemical alterations induced by precipitated nicotine withdrawal. Neuropharmacology 2015, 90:90-101. 10.1016/j.neuropharm.2014.11.013.
406. Vega-Flores G., Gruart A., Delgado-García J.M. Involvement of the GABAergic septo-hippocampal pathway in brain stimulation reward. PLoS One 2014, 9:e113787. 10.1371/journal.pone.0113787.
407. Vertkin I., Styr B., Slomowitz E., Ofir N., Shapira I., Berner D., Fedorova T., Laviv T., Barak-Broner N., Greitzer-Antes D., Gassmann M., Bettler B., Lotan I., Slutsky I. GABAB receptor deficiency causes failure of neuronal homeostasis in hippocampal networks. Proc. Natl. Acad. Sci. U. S. A. 2015, 112. E3291-9. 10.1073/pnas.1424810112.
408. Vélez-Fort M., Audinat E., Angulo M.C. Central role of GABA in neuron-glia interactions. Neuroscientist 2012, 18:237-250. 10.1177/1073858411403317.
409. Vigot R., Barbieri S., Bräuner-Osborne H., Turecek R., Shigemoto R., Zhang Y.-P., Lujan R., Jacobson L.H., Biermann B., Fritschy J.-M., Vacher C.-M., Müller M., Sansig G., Guetg N., Cryan J.F., Kaupmann K., Gassmann M., Oertner T.G., Bettler B. Differential compartmentalization and distinct functions of GABAB receptor variants. Neuron 2006, 50:589-601. 10.1016/j.neuron.2006.04.014.
410. Villette V.V., Poindessous-Jazat F.F., Bellessort B., Roullot E.E., Peterschmitt Y.Y., Epelbaum J., Stéphan A.A., Dutar P. A new neuronal target for beta-amyloid peptide in the rat hippocampus. Neurobiol. Aging 2012, 33. 1126-1114. 10.1016/j.neurobiolaging.2011.11.024.
411. Voigt R.M., Herrold A.A., Napier T.C. Baclofen facilitates the extinction of methamphetamine-induced conditioned place preference in rats. Behav. Neurosci. 2011, 125:261-267. 10.1037/a0022893.
412. Voigt R.M., Herrold A.A., Riddle J.L., Napier T.C. Administration of GABA(B) receptor positive allosteric modulators inhibit the expression of previously established methamphetamine-induced conditioned place preference. Behav. Brain Res. 2011, 216:419-423. 10.1016/j.bbr.2010.08.034.
413. Voigt R.M., Riddle J.L., Napier T.C. Effect of fendiline on the maintenance and expression of methamphetamine-induced conditioned place preference in Sprague-Dawley rats. Psychopharmacology (Berl.) 2014, 231:2019-2029. 10.1007/s00213-013-3347-7.
414. Wahlstrom-Helgren S., Klyachko V.A. GABAB Receptor-mediated feed-forward circuit dysfunction in the mouse model of fragile X syndrome. J. Physiol. 2015, 10.1113/JP271190.
415. Waldmeier P.C., Kaupmann K., Urwyler S. Roles of GABAB receptor subtypes in presynaptic auto- and heteroreceptor function regulating GABA and glutamate release. J. Neural Transm. 2008, 115:1401-1411. 10.1007/s00702-008-0095-7.
416. Wassef A., Baker J., Kochan L.D. GABA and schizophrenia: a review of basic science and clinical studies. J. Clin. Psychopharmacol. 2003, 23:601-640. 10.1097/01.jcp.0000095349.32154.a5.
417. Weis B.J., Means L.W. A comparison of the effects of medial frontal, dorsomedial thalamic, and combination lesions on discrimination and spontaneous alternation in the rat. Physiolo. Psychol. 1980, 8(September (3)):325-329.
418. White J.H., McIllhinney R.A., Wise A., Ciruela F., Chan W.Y., Emson P.C., Billinton A., Marshall F.H. The GABAB receptor interacts directly with the related transcription factors CREB2 and ATFx. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:13967-13972. 10.1073/pnas.240452197.
419. Whittington M.A., Traub R.D., Jefferys J.G. Synchronized oscillations in interneuron networks driven by metabotropic glutamate receptor activation. Nature 1995, 373:612-615. 10.1038/373612a0.
420. Wieronska J.M., Kłeczek N., Woźniak M., Gruca P., Łasoń-Tyburkiewicz M., Papp M., Brański P., Burnat G., Pilc A. mGlu5-GABAB interplay in animal models of positive, negative and cognitive symptoms of schizophrenia. Neurochem. Int. 2015, 88:97-109. 10.1016/j.neuint.2015.03.010.
421. Wilensky A.E., Schafe G.E., LeDoux J.E. The amygdala modulates memory consolidation of fear-motivated inhibitory avoidance learning but not classical fear conditioning. J. Neurosci. Org. 2000, 20:7059-7066.
422. Williams C.L., Barnett A.M., Meck W.H. Organizational effects of early gonadal secretions on sexual differentiation in spatial memory. Behav. Neurosci. 1990, 104:84-97.
423. Wilson G.N., Biesan O.R., Remus J.L., Mickley G.A. Baclofen alters gustatory discrimination capabilities and induces a conditioned taste aversion (CTA). BMC Res. Notes 2011, 4:527. 10.1186/1756-0500-4-527.
424. Winocur G. Radial-arm maze behavior by rats with dorsal hippocampal lesions: effects of cuing. J. Comp. Physiol. Psychol. 1982, 96:155-169. 10.1037/h0077882.
425. Winocur G., Wojtowicz J.M., Sekeres M., Snyder J.S., Wang S. Inhibition of neurogenesis interferes with hippocampus-dependent memory function. Hippocampus 2006, 16:296-304. 10.1002/hipo.20163.
426. Winson J. Loss of hippocampal theta rhythm results in spatial memory deficit in the rat. Science 1978, 201:160-163.
427. Workman E.R., Haddick P.C.G., Bush K., Dilly G.A., Niere F., Zemelman B.V., Raab-Graham K.F. Rapid antidepressants stimulate the decoupling of GABAB receptors from GIRK/Kir3 channels through increased protein stability of 14-3-3η. Mol. Psychiatry 2015, 10.1038/mp.2014.165.
428. Workman E.R., Niere F., Raab-Graham K.F. mTORC1-dependent protein synthesis underlying rapid antidepressant effect requires GABABR signaling. Neuropharmacology 2013, 73:192-203. 10.1016/j.neuropharm.2013.05.037.
429. Wu Y., Chan K.F.Y., Eubanks J.H., Wong C.G.T., Cortez M.A., Shen L., Liu C.C., Velazquez J.P., Wang Y.T., Jia Z., Snead O.C. Transgenic mice over-expressing GABA(B)R1a receptors acquire an atypical absence epilepsy-like phenotype. Neurobiol. Dis. 2007, 26:439-451.
430. Wu Z., Guo Z., Gearing M., Chen G. Tonic inhibition in dentate gyrus impairs long-term potentiation and memory in an Alzhiemer's disease model. Nat. Commun. 2014, 5:4159. 10.1038/ncomms5159.
431. Xiao Y., Huang X.-Y., Van Wert S., Barreto E., Wu J.-Y., Gluckman B.J., Schiff S.J. The role of inhibition in oscillatory wave dynamics in the cortex. Eur. J. Neurosci. 2012, 36:2201-2212. 10.1111/j. 1460-9568.2012.08132.x.
432. Yamamoto T., Fujimoto Y. Brain mechanisms of taste aversion learning in the rat. Brain Res. Bull. 1991, 27:403-406. 10.1016/0361-9230(91) 90133-5.
433. Yamamoto T., Fujimoto Y., Shimura T., Sakai N. Conditioned taste aversion in rats with excitotoxic brain lesions. Neurosci. Res. 1995, 22:31-49.
434. Yarishkin O., Lee J., Jo S., Hwang E.M. Disinhibitory action of astrocytic GABA at the perforant path to dentate gyrus granule neuron synapse reverses to inhibitory in Alzheimer's disease model. Exp. Neurobiol. 2015, 24:211-218. 10.5607/en.2015.24.3.211.
435. Yirmiya R., Goshen I. Immune modulation of learning, memory, neural plasticity and neurogenesis. Brain Behav. Immun. 2011, 25:181-213. 10.1016/j.bbi.2010.10.015.
436. Yoon B.-E., Lee C.J. GABA as a rising gliotransmitter. Front Neural Circuits 2014, 8. 10.3389/fncir.2014.00141.
437. Young L.J. The neurobiology of social recognition, approach, and avoidance. Biol. Psychiatry 2002, 51:18-26.
438. Yu Z., Cheng G., Hu B. Mechanism of colchicine impairment on learning and memory, and protective effect of CGP 36742 in mice. Brain Res. 1997, 750:53-58.
439. Zarrindast M.-R., Lahiji P., Shafaghi B., Sadegh M. Effects of GABAergic drugs on physostigmine-induced improvement in memory acquisition of passive avoidance learning in mice. Gen. Pharmacol. 1998, 31:81-86.
440. Zarrindast M.-R., Bakhsha A., Rostami P., Shafaghi B. Effects of intrahippocampal injection of GABAergic drugs on memory retention of passive avoidance learning in rats. J. Psychopharmacol. 2002, 16:313-319.
441. Zarrindast M.-R., Haidari H., Jafari M.R., Djahanguiri B. Influence of beta-adrenoceptor agonists and antagonists on baclofen-induced memory impairment in mice. Behav. Pharmacol. 2004, 15:293-297.
442. Zarrindast M.-R., Shamsi T., Azarmina P., Rostami P., Shafaghi B. GABAergic system and imipramine-induced impairment of memory retention in rats. Eur. Neuropsychopharmacol. 2004, 14:59-64. 10.1016/S0924-977X(03)00068-3.
443. Zarrindast M.-R., Massoudi R., Sepehri H., Rezayof A. Involvement of GABA B receptors of the dorsal hippocampus on the acquisition and expression of morphine-induced place preference in rats. Physiol. Behav. 2006, 87:31-38.
444. Zarrindast M.-R., Noorbakhshnia M., Motamedi F., Haeri-Rohani A., Rezayof A. Effect of the GABAergic system on memory formation and state-dependent learning induced by morphine in rats. Pharmacology 2006, 76:93-100. 10.1159/000089934.
445. Zarrindast M.-R., Hoghooghi V., Rezayof A. Inhibition of morphine-induced amnesia in morphine-sensitized mice: involvement of dorsal hippocampal GABAergic receptors. Neuropharmacology 2008, 54:569-576. 10.1016/j.neuropharm.2007.11.004.
446. Zeman A., Hoefeijzers S., Milton F., Dewar M., Carr M., Streatfield C. The GABAB receptor agonist, baclofen, contributes to three distinct varieties of amnesia in the human brain-a detailed case report. Cortex 2016, 74:9-19. 10.1016/j.cortex.2015.10.005.
447. Zhang Y., Fukushima H., Kida S. Induction and requirement of gene expression in the anterior cingulate cortex and medial prefrontal cortex for the consolidation of inhibitory avoidance memory. Mol. Brain 2011, 4. 10.1186/1756-6606-4-4.
448. Zhao X., Qin S., Shi Y., Zhang A., Zhang J., Bian L., Wan C., Feng G., Gu N., Zhang G., He G., He L. Systematic study of association of four GABAergic genes: glutamic acid decarboxylase 1 gene, glutamic acid decarboxylase 2 gene, GABA(B) receptor 1 gene and GABA(A) receptor subunit beta2 gene, with schizophrenia using a universal DNA microarray. Schizophr. Res. 2007, 93:374-384. 10.1016/j.schres.2007.02.023.